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A B S T R A C T
Background
A previous version of this Cochrane Review identified that insecticide-treated nets (ITNs) are effective at reducing child mortality,
parasite prevalence, and uncomplicated and severe malaria episodes. Insecticide-treated nets have since become a core intervention for
malaria control and have contributed greatly to the dramatic decline in disease incidence and malaria-related deaths seen since the turn
of the millennium. However, this time period has also seen a rise in resistance to pyrethroids (the insecticide used in ITNs), raising
questions over whether the evidence from trials conducted before resistance became widespread can be applied to estimate the impact
of ITNs on malaria transmission today.
Objectives
The primary objective of this review was to assess the impact of ITNs on mortality and malaria morbidity, incorporating any evidence
published since the previous update into new and existing analyses, and assessing the certainty of the resulting evidence using GRADE.
Search methods
We searched the Cochrane Infectious Diseases Group Specialized Register, the Cochrane Central Register of Controlled Trials (CEN-
TRAL) published in the Cochrane Library, MEDLINE, Embase, LILACS, the World Health Organization (WHO) International
Clinical Trials Registry Platform, ClinicalTrials.gov, and the ISRCTN registry for new trials published since 2004 and up to 18 April
2018.
Selection criteria
We included individual randomized controlled trials (RCTs) and cluster RCTs comparing bed nets or curtains treated with a synthetic
pyrethroid insecticide at a minimum target impregnation dose recommended by the WHO with no nets or untreated nets.
Data collection and analysis
One review author assessed the identified trials for eligibility and risk of bias, and extracted data. We compared intervention and control
data using risk ratios (RRs), rate ratios, and mean differences, and presented all results with their associated 95% confidence intervals
(CIs). We assessed the certainty of evidence using the GRADE approach. We drew on evidence from a meta-analysis of entomological
outcomes stratified by insecticide resistance from 2014 to inform the GRADE assessments.
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Main results
Our updated search identified three new trials. A total of 23 trials met the inclusion criteria, enrolling more than 275,793 adults and
children. The included studies were conducted between 1987 and 2001.
ITN versus no nets
Insecticide-treated nets reduce child mortality from all causes by 17% compared to no nets (rate ratio 0.83, 95% CI 0.77 to 0.89;
5 trials, 200,833 participants, high-certainty evidence). This corresponds to a saving of 5.6 lives (95% CI 3.6 to 7.6) each year for
every 1000 children protected with ITNs. Insecticide-treated nets also reduce the incidence of uncomplicated episodes of Plasmodium
falciparum malaria by almost a half (rate ratio 0.55, 95% CI 0.48 to 0.64; 5 trials, 35,551 participants, high-certainty evidence) and
probably reduce the incidence of uncomplicated episodes of Plasmodium vivax malaria (risk ratio (RR) 0.61, 95% CI 0.48 to 0.77; 2
trials, 10,967 participants, moderate-certainty evidence).
Insecticide-treated nets were also shown to reduce the prevalence of P falciparummalaria by 17% compared to no nets (RR 0.83, 95%
CI 0.71 to 0.98; 6 trials, 18,809 participants, high-certainty evidence) but may have little or no effect on the prevalence of P vivax
malaria (RR 1.00, 95% CI 0.75 to 1.34; 2 trials, 10,967 participants, low-certainty evidence). A 44% reduction in the incidence of
severe malaria episodes was seen in the ITN group (rate ratio 0.56, 95% CI 0.38 to 0.82; 2 trials, 31,173 participants, high-certainty
evidence), as well as an increase in mean haemoglobin (expressed as mean packed cell volume) compared to the no-net group (mean
difference 1.29, 95% CI 0.42 to 2.16; 5 trials, 11,489 participants, high-certainty evidence).
ITN versus untreated nets
Insecticide-treated nets probably reduce child mortality from all causes by a third compared to untreated nets (rate ratio 0.67, 95%
CI 0.36 to 1.23; 2 trials, 25,389 participants, moderate-certainty evidence). This corresponds to a saving of 3.5 lives (95% CI -2.4
to 6.8) each year for every 1000 children protected with ITNs. Insecticide-treated nets also reduce the incidence of uncomplicated P
falciparum malaria episodes (rate ratio 0.58, 95% CI 0.44 to 0.78; 5 trials, 2036 participants, high-certainty evidence) and may also
reduce the incidence of uncomplicated P vixaxmalaria episodes (rate ratio 0.73, 95% CI 0.51 to 1.05; 3 trials, 1535 participants, low-
certainty evidence).
Use of an ITN probably reduces P falciparum prevalence by one-tenth in comparison to use of untreated nets (RR 0.91, 95% CI 0.78
to 1.05; 3 trials, 2,259 participants, moderate-certainty evidence). However, based on the current evidence it is unclear whether or not
ITNs impact on P vivax prevalence (1 trial, 350 participants, very low certainty evidence) or mean packed cell volume (2 trials, 1,909
participants, low certainty evidence).
Authors’ conclusions
Although there is some evidence that insecticide resistance frequency has some effects on mosquito mortality, it is unclear how
quantitatively important this is. It appeared insufficient to downgrade the strong evidence of benefit on mortality and malaria illness
from the trials conducted earlier
P L A I N L A N G U A G E S U M M A R Y
Insecticide-treated nets for preventing malaria
What is the aim of this review?
Insecticide-treated nets (ITNs) are a core intervention for malaria control. A previous version of this Cochrane Review showed they
are very effective at reducing malaria-related death and illness. Since the review was published, many areas affected by malaria have
reported mosquito populations that are resistant to the insecticides used in ITNs. The aim of this review update was to evaluate the
available evidence and find out whether ITNs continue to be effective at controlling the disease. Cochrane researchers collected and
analysed relevant studies and assessed the overall certainty of the evidence.
What was studied in the review?
This review update summarized trials published since the previous review that evaluated the impact of ITNs on malaria-related deaths
and illness, compared to both no nets and untreated nets. After searching for relevant trials up to 18 April 2018, we identified three
new randomized controlled trials (studies in which participants are assigned to a treatment group using a random method). In total, we
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included 23 trials, enrolling more than 275,000 adults and children, to evaluate the effectiveness of ITNs for reducing the burden of
malaria. The included studies provided evidence of the impact of ITNs on infection from two types of malaria parasites, Plasmodium
falciparum and Plasmodium vivax.
What are the main results of the review?
Twelve trials (nine in Africa, one in Cambodia, one in Myanmar, and one in Pakistan) assessed the impact of ITNs in comparison to
no nets. From these trials, we concluded that ITNs reduce the child mortality from all causes, corresponding to a saving of 5.6 lives
each year for every 1000 children protected with ITNs (high-certainty evidence). ITNs also reduce the number of P falciparum cases
per person per year and the proportion of people infected with P falciparum parasites (high-certainty evidence). ITNs probably reduce
the number of P vivax cases per person per year and may reduce the proportion of people infected with P vivax parasites (moderate-
certainty evidence).
Eleven trials (three in sub-Saharan Africa, six in Latin America, and two in Thailand) assessed the impact of ITNs in comparison to
untreated nets. From these trials, we concluded that ITNs probably reduce the child mortality from all causes, corresponding to a saving
of 3.5 lives each year for every 1000 children protected with ITNs (moderate-certainty evidence). ITNs also reduce the number of P
falciparum cases per person per year (high-certainty evidence), and probably reduce the proportion of people infected with P falciparum
parasites (moderate-certainty evidence). Whilst ITNs may also reduce the number of P vivax cases per person per year (low-certainty
evidence), it is unclear if the proportion of people infected with P vivax parasites is any lower in those using an ITN than those using
an untreated net (very low certainty evidence).
In interpreting these results, we considered that there are a growing number of mosquito populations that have been shown to be able
to survive exposure to the insecticides used in ITNs. However, it is currently unclear how quantitatively important this is, and this
seems insufficient to downgrade the existing evidence of an effect of ITNs in preventing malaria-related mortality and illness.
Key messages
ITNs, whether compared to no nets or to untreated nets, continue to be effective at reducing child mortality and malaria-related illness
in affected areas.
3Insecticide-treated nets for preventing malaria (Review)
Copyright © 2018 The Authors. Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The
Cochrane Collaboration.
S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Insecticide- treated bed nets and curtains (ITNs) compared to no nets for preventing malaria
Patient or population: people of all ages living in malaria transmission sett ings
Setting: Burkina Faso 1996 (Halbluetzel 1996); Cameroon 1992 (Moyou-Somo 1995); Cambodia 2002 (Sochantha 2006); Ghana 1995 (Binka 1996); Ivory Coast 2000 (Henry
2005); Kenya 1988 (Sexton 1990); Kenya 1995 (Nevill 1996) and 1998 (Phillips-Howard 2003); Myanmar 1999 (Smithuis 2013); Sierra Leone 1993 (Marbiah 1998); Pakistan
1991 (Rowland 1996); Tanzania 1996 (Fraser-Hurt 1999)
Intervention: ITNs
Comparison: no nets
Outcomes Anticipated absolute effects∗ (95% CI) Relative effect
(95% CI)
Number of participants
(trials)
Certainty of the evi-
dence
(GRADE)
Comments
Risk with no nets Risk with ITNs
Child mortality f rom all
causes
Children of all ages Rate rat io 0.83
(0.77 to 0.89)
200,833
(5 RCTs)
⊕⊕⊕⊕
HIGHa
Insect icide-treated bed
nets and curtains re-
duce all-cause child
mortality compared to
no nets
32.9 per 1000 27.3 per 1000
(25.3 to 29.3)
Children aged 1 to 59 months
37.8 per 1000 31.4 per 1000
(29.1 to 33.6)
Plasmodium fal-
ciparum uncomplicated
episodesg
178 per 1000 96 per 1000
(86 to 107)
Rate rat io 0.55
(0.48 to 0.64)
35,551
(5 RCTs)
⊕⊕⊕⊕
HIGHa
Insect icide-treated bed
nets and curtains re-
duce the incidence of
uncom-
plicated episodes of P
falciparum malaria com-
pared to no nets.
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Plasmodium vivax un-
complicated episodes
(cumulat ive incidence)
149 per 1000 91 per 1000
(71 to 114)
Risk rat io 0.61
(0.48 to 0.77)
10,967
(2 RCTs)
⊕⊕⊕©
MODERATEa,b
due to indirectness
Insect icide-treated bed
nets and curtains prob-
ably reduce the in-
cidence of uncompli-
cated episodes of P vi-
vax malaria compared
to no nets.
Any Plas-
modium spp. uncompli-
cated episodes
256 per 1000 128 per 1000
(72 to 231)
Rate rat io 0.50
(0.28 to 0.90)
8,395
(1 RCT)
⊕⊕©©
LOWa,c,d
due to indirectness
Insect icide-treated bed
nets and curtains
may reduce the in-
cidence of uncom-
plicated episodes of
any Plasmodium species
compared to no nets.
P falciparum prevalence 147 per 1000 122 per 1000
(102 to 144)
Risk rat io 0.83
(0.71 to 0.98)
18,809
(6 RCTs)
⊕⊕⊕⊕
HIGHa
Insect icide-treated bed
nets and curtains re-
duce the prevalence
of P falciparum malaria
compared to no nets.
P vivax prevalence 130 per 1000 130 per 1000
(98 to 175)
Risk rat io 1.00
(0.75 to 1.34)
10,967
(2 RCTs)
⊕⊕©©
LOWa,b,e
due to indirectness and im-
precision
Insect icide-treated bed
nets and curtains may
have lit t le or no ef fect
on the prevalence of P
vivaxmalaria compared
to no nets.
Severe malaria
episodes
15.1 per 1000 8.5 per 1000
(5.7 to 12.4)
Rate rat io 0.56
(0.38 to 0.82)
31,173
(2 RCTs)
⊕⊕⊕⊕
HIGHa
Insect icide-treated bed
nets and curtains re-
duce the incidence
of severe malaria
episodes compared to
no nets
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Anaemia (mean packed
cell volume)
31.4 32.7 (31.8 to 33.6) Mean dif ference 1.29
(0.42 to 2.16)
11,489
(5 RCTs)
⊕⊕⊕⊕
HIGHa,f
Insect icide-treated bed
nets and curtains
increase the mean
packed cell volume
compared to no nets
*The risk in the intervention group (and its 95%CI) is based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its 95%CI).
Abbreviations: CI: conf idence interval; RCT: randomized controlled trial; ITN: Insect icide-treated net
GRADE Working Group grades of evidence
High certainty: we are very conf ident that the true ef fect lies close to that of the est imate of the ef fect.
Moderate certainty: we are moderately conf ident in the ef fect est imate: the true ef fect is likely to be close to the est imate of the ef fect, but there is a possibility that it is
substant ially dif f erent.
Low certainty: our conf idence in the ef fect est imate is lim ited: the true ef fect may be substant ially dif f erent f rom the est imate of the ef fect.
Very low certainty: we have very lit t le conf idence in the ef fect est imate: the true ef fect is likely to be substant ially dif f erent f rom the est imate of ef fect
aNot downgraded for indirectness: for most included studies, it is unclear whether insect icide resistance was present. The
review authors judge that there is not convincing evidence that insect icide resistance would reduce the impact of ITNs on
the included epidemiological outcomes. A previous review that included entomological outcomes showed the dif ference in
mosquito mortality risk using ITNs compared with untreated nets modest ly decreased as insect icide resistance increased
(Strode 2014). However, mosquito mortality risk remained signif icant ly higher for ITNs than for untreated nets, regardless
of the resistance status.
bDowngraded one level for indirectness: most data are provided by a trial in two refugee camps in Pakistan. The second trial
is in Myanmar and provides data only for children younger than 10 years. It is not clear how conf ident ly the information can
be applied to other populat ions.
cNot downgraded for imprecision: the smallest ef fect size is st ill a sizable a reduct ion of 56 episodes per 1000 child-years.
dDowngraded two levels for indirectness: the evidence comes f rom one trial only, which was conducted in Myanmar, and in
which part icipants were exclusively children aged younger than 10 years. It is not clear how conf ident ly the information can
be applied to other populat ions.
eDowngraded one level for imprecision: the conf idence interval includes both a sizable increase and decrease in prevalence.
fNot downgraded for inconsistency: although the I2 of 69% indicated substant ial heterogeneity, ITNs showed an increase in
mean packed cell volume universally across each of the f ive trials.
gThe cumulat ive incidence of P falciparum clinical episodes was also reported (Analysis 1.3: RR 0.44, 95% CI 0.31 to 0.62;
moderate-certainty evidence). As this is consistent with the ef fect on the incidence rate, we did not present both results in the
‘Summary of f indings’ table.
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B A C K G R O U N D
The 2004 Cochrane Review ‘Insecticide-treated bed nets and cur-
tains for preventing malaria’ demonstrated the effectiveness of in-
secticide-treatednets (ITNs) for reducingmalaria prevalence,mor-
bidity, andmortality. Incorporating information from22 random-
ized controlled trials (RCTs), the review found that ITNs reduced
child mortality by 17%. In areas of stable malaria transmission,
ITNs also reduced parasite prevalence by 13%, uncomplicated
malaria episodes by 50%, and severe malaria by 45% compared to
equivalent populations with no nets (Lengeler 2004). The World
Health Organization (WHO) now recommends ITNs as a core
intervention for malaria control.
Between 2010 and 2015, the estimated percentage of the at-risk
population sleeping under an ITN rose from 30% to 53%. Dur-
ing this time, disease incidence and malaria-related deaths have
fallen by 21% and 29%, respectively (WHO 2016). Additionally,
parasite prevalence in endemic sub-Saharan Africa decreased by
50% between 2001 and 2015, with 68% of this decline attributed
to the use of ITNs (Bhatt 2015)
Emerging insecticide resistance poses a challenge to current
malaria vector control methods. There are only four classes of in-
secticide in use for public health, with just two mechanisms of
action. A lack of funding for research into new insecticides has
meant that the most recently developed class is the pyrethroids,
which were developed over 40 years ago (Ranson 2011). During
this period, 27 countries have reported resistance to pyrethroids,
and the number of susceptible Anopheles populations continues to
decline (Ranson 2016). The effectiveness of ITNs is particularly
at risk, as pyrethroids are the only class of insecticide considered
safe for prolonged human contact and therefore appropriate for
ITN use (Zaim 2000).
Insecticide resistance is commonly detected using laboratory-
based bioassays and experimental hut studies, but these do not
necessarily indicate reduced ITN impact on real-life clinical out-
comes (Ranson 2016). It remains unclear whether the dramatic
increases in ITN use and pyrethroid resistance in the years follow-
ing Lengeler’s 2004 review have reduced the clinical effectiveness
of ITNs. The purpose of this review update was therefore to iden-
tify, critically appraise, and summarize any trials published since
the last edition of the review, incorporating modern methods for
systematic reviews that allow combined analysis of cluster RCTs
(cRCTs), and assessment of the certainty of the estimates of the
effect of ITNs. We were able to draw on a systematic review of
entomological outcomes in the presence of pyrethroid resistance
from 2014 to help inform the GRADE assessments for indirect-
ness (Strode 2014).
O B J E C T I V E S
The primary objective of this review was to assess the impact of
ITNs on mortality and malaria morbidity, incorporating any evi-
dence published since the previous update into new and existing
analyses, and assessing the certainty of the resulting evidence using
GRADE.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Individual RCTs and cluster RCTs (cRCTs).
Types of participants
Children and adults living in malaria transmission settings.
We excluded trials examining only pregnant women, because these
are reviewed elsewhere (Gamble 2006), and trials examining only
soldiers or travellers, as these are not representative of the general
population.
Types of interventions
Bed nets or curtains treated with a synthetic pyrethroid insecticide
at a minimum target impregnation dose recommended by the
WHO, which is as follows.
• 200 mg/m2 permethrin or etofenprox.
• 30 mg/m2 cyfluthrin.
• 20 mg/m2 alpha-cypermethrin.
• 10 mg/m2 deltamethrin/lambda-cyhalothrin.
No distinction was made between insecticide-treated bed nets and
door/window/eave/wall curtains.
Control populations were those provided with either no net or
with an untreated net.
Types of outcome measures
Primary outcomes
• Child mortality from all causes.
Secondary outcomes
• Uncomplicated clinical episodes: measured using site-
specific definitions, including measured or reported fever, with
or without parasitological confirmation. Measurements were
usually done in the frame of prospective longitudinal studies, as a
rate of episodes per unit of time (incidence). We also included
trials using validated retrospective assessments in the frame of
7Insecticide-treated nets for preventing malaria (Review)
Copyright © 2018 The Authors. Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The
Cochrane Collaboration.
cross-sectional surveys, providing a percentage of the population
who had experienced an uncomplicated episode in a unit of time
(cumulative incidence). When reported separately, P falciparum
and P vivax episodes were analysed separately. We also included
trials that reported the incidence of episodes of any Plasmodium
species.
• Parasite prevalence: parasite prevalence due to P falciparum
and P vivax was obtained using the site-specific method for
estimating parasitaemia, usually thick or thin blood smears or
both. When more than one survey was done, the reported
prevalence result is the average prevalence of all the surveys.
• Severe disease: measured using site-specific definitions,
which were based on the WHO guidelines, WHO 1990, and on
Marsh 1995. The definition included P falciparum parasitaemia.
Cerebral malaria was defined as coma or prostration and/or
multiple seizures. The cut-off for severe, life-threatening anaemia
was set at 5.1 g/L (WHO 1990).
• Anaemia: expressed in mean packed cell volume (PCV),
equivalent to the percentage haematocrit. Results given in grams
per decilitre were converted with a standard factor of 3:1 so that
1 g/dL equals 3% PCV.
• The outcome measures below were considered in the
previous review (Lengeler 2004), but were not considered
priority outcomes at the time of this update and were therefore
not included. Appendix 1 details the full inclusion criteria for
this previous update.
◦ High parasitaemia: measured using site-specific
definitions of high parasitaemia, provided the cut-off value
between high and low was determined prior to data analysis.
◦ Splenomegaly: measured in all trials using the Hackett
scale.
◦ Anthropometric measures: standard anthropological
measures (weight-for-age, height-for-age, weight-for-height,
skinfold thickness, or mid-upper arm circumference)
Search methods for identification of studies
The previous review, Lengeler 2004, used the search strategy out-
lined below to identify included studies.
• The following databases were searched using the search
terms and strategy described in Appendix 2: Cochrane Infectious
Diseases Group Specialized Register (January 2003); Cochrane
Central Register of Controlled Trials (CENTRAL), published in
the Cochrane Library (Issue 1, 2003); MEDLINE (1966 to
October 2003); Embase (1974 to November 2002); and
LILACS (Latin American and Caribbean Health Science
Information database) (1982 to January 2003).
• The following foreign language tropical medicine journals
were handsearched, covering the period from 1980 to 1997:
Bulletin OCEAC, Bulletin de la Société de Pathologie Exotique,
Médecine Tropicale, and Revista do Instituto de Medicina Tropical
de Sao Paulo.
• Researchers actively involved in the field of ITNs were
contacted and asked about unpublished past or ongoing work.
• The following agencies, which have funded ITN trials, were
contacted: UNDP/World Bank/WHO Special Programme for
Research and Training in Tropical Diseases (TDR); International
Development Research Centre (IDRC), Canada; the
Department for International Development, UK; and the
European Union Directorate-General XII.
• The following manufacturers of pyrethroids used for
treating netting were contacted: AgrEvo (now part of Bayer),
Bayer, Cyanamid, Mitsui, Sumitomo, and Zeneca (now part of
Syngenta).
• The following reviews were consulted: Abdulla 1995;
Bermejo 1992; Carnevale 1991; Cattani 1997; Choi 1995;
Curtis 1992; Molyneaux 1994; Rozendaal 1989; Sexton 1994;
Voorham 1997; WHO 1989; Xu 1988; Yadav 1997; and
Zimmerman 1997.
• The following books on the subject of ITNs were consulted:
Control of Disease Vectors in the Community (Curtis 1991),
Malaria: Waiting for the Vaccine (Targett 1991), and Net Gain, a
New Method for Preventing Malaria Deaths (Lengeler 1996).
• The reference lists of all trials identified by the above
methods were consulted.
We considered for this review update all studies identified using
the strategy above. Detailed below is the additional search process
we undertook to identify new studies conducted since 2003.
Electronic searches
We searched the following databases, using the search terms and
strategy described in Appendix 2: Cochrane Infectious Diseases
Group Specialized Register (2003 to 18 April 2018); Cochrane
Central Register of Controlled Trials ( Issue 4, 2018); MEDLINE
( PubMed, 2003 to 18 April 2018); Embase ( Ovid, January 2003
to 18 April 2018); and LILACS ( Latin American and Caribbean
Health Science Information database) ( 2003 to 18 April 2018).
To identify any ongoing trials, we also searched the World Health
Organization ( WHO) International Clinical Trials Registry Plat-
form ( www.who.int/ictrp/search/en/; 18 April 2018), Clinical-
Trials.gov ( https://clinicaltrials.gov/; 18 April 2018) and the IS-
RCTN registry ( www.isrctn.com/; 18 April 2018)
Searching other resources
We contacted organizations, including the WHO and the Cen-
ters for Disease Control and Prevention (CDC), for ongoing and
unpublished trials. The reference lists of all trials identified by the
above methods were also consulted.
Data collection and analysis
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Selection of studies
One review author (JP) screened the titles and abstracts of arti-
cles identified by the literature searches for potential inclusion in
the review. The full-text articles of potentially relevant trials were
assessed using an eligibility form based on the inclusion criteria.
Multiple publications of the same trial were included only once.
Excluded studies are listed together with their reasons for exclusion
in the Characteristics of excluded studies table.We have illustrated
the study selection process in a PRISMA diagram (see Figure 1).
Figure 1. Study flow diagram.
Data extraction and management
One review author (JP) extracted information from each of the
included studies (identified in both search processes) using pre-
piloted electronic data extraction forms. In the case of missing data
in studies from the initial search, we contacted the original study
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authors or the author of the original review (CL) for confirmation.
In case of missing data in newly identified studies, we contacted
the original study authors for clarification.
We extracted data on the following.
• Trial design: type of trial; length of follow-up; method of
participant selection; sample size; and method of blinding of
participants and personnel. For cRCTs we also recorded the
number of clusters randomized, the number of clusters analysed,
and method of adjustment for clustering.
• Participants: number of participants; inclusion/exclusion
criteria.
• Intervention: description of intervention (active ingredient,
dose, retreatment times, type of net); description of control.
• Outcomes: definition of outcomes; diagnostic method or
surveillance method; passive or active case detection.
• Other: study location; malaria endemicity, entomological
inoculation rate (EIR), primary vector species; Plasmodium
species.
For dichotomous outcomes, we extracted the number of partici-
pants who experienced each outcome and the total number of par-
ticipants in each treatment group. Where trials conducted multi-
ple cross-sectional surveys during the intervention period, we took
an average of the numerators and denominators across the total
number of surveys. We selected this procedure in order to avoid
inflating the denominator artificially by adding up the participants
from repeated surveys. For count data outcomes, we extracted the
number of outcomes in the treatment and control groups and the
total person-time at risk in each group, or the rate ratio and a
measure of variance (for example, standard error). For continuous
outcomes, we extracted the mean and a measure of variance (stan-
dard deviation).
We considered the impact of ITNs on the primary outcome of
child mortality from all causes likely to be age-dependent. In ad-
dition to extracting the total number of deaths in the total study
population, where possible we extracted the number of deaths and
total number of children within a high-risk age group of 1 to 59
months. This allowed an estimate for each age group of the num-
ber of deaths that can be avoided through the provision of ITNs.
Assessment of risk of bias in included studies
We assessed the risk of bias for each study using the Cochrane
‘Risk of bias’ tool (Higgins 2011). For each included cRCT,we also
assessed the five additional criteria relating specifically to cRCTs
listed in Section 16.3.2 of the Cochrane Handbook for Systematic
Reviews of Interventions. We classified judgements of risk of bias as
either low, high, or unclear risk of bias. We have summarized the
results of the assessment in a ‘Risk of bias’ summary figure.
Measures of treatment effect
We compared intervention and control data using rate ratios, risk
ratios (RRs), and mean differences, and presented all results with
their associated 95% confidence intervals (CIs).
Unit of analysis issues
If included cRCTs had not adjusted for clustering in the analysis,
we adjusted the data before combining it. We adjusted data by
multiplying the standard errors by the square root of the design
effect (Higgins 2011), which is determined by the intracluster
correlation coefficient (ICC). If the trial did not report the ICC
value, we used the ICC from a similar trial that reported the same
outcome (Smithuis 2013).
Dealing with missing data
In case of missing data, we applied available-case analysis, only in-
cluding data on the known results. The denominator was the total
number of participants who had data recorded for the specific out-
come. For outcomes with no missing data, we performed analyses
on an intention-to-treat basis. We included all participants ran-
domized to each group in the analyses and analysed participants
in the group to which they were randomized.
Assessment of heterogeneity
We inspected forest plots for overlapping CIs and assessed statis-
tical heterogeneity in each meta-analysis using the I2 statistic and
Chi2 test values. We considered I2 statistic values between 30%
and 60% indicative of moderate heterogeneity; between 50% and
90% substantial heterogeneity; and between 75% and 100% con-
siderable heterogeneity. We considered a Chi2 test statistic with a
P value greater than 0.10 indicative of statistically significant het-
erogeneity. We explored clinical and methodological heterogene-
ity through consideration of the trial populations, methods, and
interventions, and by visualization of trial results.
Assessment of reporting biases
We intended to investigate reporting biases (such as publication
bias) by assessing funnel plot asymmetry (Harbord 2006). How-
ever, as each meta-analysis included fewer than 10 trials, such an
assessment was not possible.
Data synthesis
We analysed data using Review Manager 5 (RevMan 2014). As
we detected no heterogeneity between the study types, we pooled
data from both individual RCTs and cluster-adjusted cRCTs in a
meta-analysis (Richardson 2016).
Based on the consideration of clinical, epidemiological, and
methodological heterogeneity between the trials, we used a ran-
dom-effects model.
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Certainty of the evidence
We assessed the certainty of the evidence using the GRADE ap-
proach (Guyatt 2011), rating each outcome as follows.
• High: we are very confident that the true effect lies close to
that of the estimate of the effect.
• Moderate: we are moderately confident in the effect
estimate: the true effect is likely to be close to the estimate of the
effect.
• Low: our confidence in the effect estimate is limited: the
true effect may be substantially different from the estimate of the
effect.
• Very low: we have very little confidence in the effect
estimate: the true effect is likely to be substantially different from
the estimate of effect.
As all the included studies were RCTs, the evidence for each out-
come started as high certainty, but could be downgraded if there
were valid reasons to do so within the following five categories:
risk of bias, imprecision, inconsistency, indirectness, and publi-
cation bias (Balshem 2011). We summarized the certainty of the
evidence for each outcome in a ’Summary of findings’ table.
We drew on a review of entomological outcomes in the presence
of insecticide resistance to inform our indirectness judgement in
GRADE (Strode 2014).
Subgroup analysis and investigation of heterogeneity
Weplanned that if we detected substantial heterogeneity, wewould
perform a subgroup analysis of malaria transmission stability (sta-
ble malaria defined as an EIR of 1.0 and above, or unstable malaria
defined as an EIR of less than 1.0). We additionally intended to
subgroup cRCTs and individual RCTs. However, we detected sub-
stantial heterogeneity in only one meta-analysis, and as all of the
included studies were cRCTs conducted in unstable malaria areas,
the subgroup analyses would not have provided any insight into
the heterogeneity.
Sensitivity analysis
We intended to perform a sensitivity analysis on the primary out-
come to determine the effect of exclusion of trials judged to have
a serious risk of bias, but we identified no such studies.
R E S U L T S
Description of studies
Results of the search
Our search of the databases identified a total of 333 new records.
We considered 20 articles for full-text screening following title
and abstract screening. From these, we identified three articles,
reporting three new trials, that met our inclusion criteria, and five
new articles relating to trials included in the previous update. The
search also returned five articles that were included and referenced
in the previous review. The remaining seven trials were excluded.
We also screened the full texts of the 22 trials included in the
previous version of the review against the inclusion criteria of
the review update. Of these, we identified 20 trials for inclu-
sion in the updated review. One record described four individual
trials, conducted in separate regions of Latin America (Kroeger
1995 (Colombia); Kroeger 1995 (Ecuador); Kroeger 1995 (Peru
Amazon); Kroeger 1995 (Peru Coast)). The study selection pro-
cess is shown in Figure 1.
Included studies
Trial design and location
Of the 23 RCTs meeting the inclusion criteria, two were individu-
ally randomized. The remaining 21 trials were cRCTs. In 15 trials,
the unit of randomization was the village or larger administration
unit, while six trials used households as the unit of randomization.
The two individual RCTs were analysed on an intention-to-treat
basis.
Twelve trials were conducted in sub-Saharan Africa (Burkina Faso,
Cameroon, Gambia (2), Ghana, Ivory Coast, Kenya (3), Mada-
gascar, Sierra Leone, and Tanzania). Six trials were conducted
in Latin America (Colombia, Ecuador, Nicaragua, Peru (2), and
Venezuela). Four trials were conducted in the Greater Mekong
subregion (Cambodia, Myanmar, and Thailand (2)), and one trial
was conducted in Pakistan.
The three trials new to this update were cRCTs conducted in
Cambodia, Myanmar, and Venezuela.
Participants
Eleven trials included the whole population of selected areas (typ-
ically in low-endemicity areas), while 12 trials restricted par-
ticipation to specific age groups (typically children in high-en-
demicity areas). Two studies were conducted specifically in dis-
placed-persons camps (Luxemburger 1994; Rowland 1996), and
one study was restricted solely to migrant workers in the area
(Kamol-Ratanakul 1992).
Intervention
The trials examined the impact of insecticide-treated bed nets (n
= 19), treated hammock nets (n = 2), or treated curtains (n = 2).
Additionally, one trial compared treated nets, treated curtains, and
no bed nets or curtains (Sexton 1990).
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In some trials the intervention consisted of treating existing nets
with an insecticide (‘treatment of nets’), while in other trials the
investigators provided treated mosquito nets or curtains to the
population (‘treated nets’ and ‘treated curtains’).
Most nets or curtains were treated with permethrin (200 mg/m
2 (n = 3), 500 mg/m2 (n = 9), or 1000 mg/m2 (n = 1)). The
remaining nets or curtains were treated with lambda-cyhalothrin
(10 to 30 mg/m2; n = 5) or deltamethrin (25 mg/m2; n = 4), while
one study used lambda-cyhalothrin (10 mg/m2) for the first year
and permethrin (500 mg/m2) for the second year (Kroeger 1995
(Peru Coast)).
Approximately half of the trials used untreated nets as a control (n
= 11), while the remaining trials used no net or curtain as a control
(n = 12). The usage rate of the untreated nets was high (> 80%),
except in one region in Peru, in which it was 63% (Kroeger 1995
(Peru Coast)), and in the Gambia (D’Alessandro 1995), in which
it varied between 50% and 90% according to the area. No usage
rate was provided for Rabarison 1995, Magris 2007, or Smithuis
2013.
Outcomes
Seven trials reported on our primary outcome of child mortality
from all causes. Of these, six were conducted in highly malaria
endemic areas in sub-Saharan Africa, and one was in conducted in
Myanmar (Smithuis 2013). Two studies reported on the incidence
of severe malaria episodes. Other outcomes reported throughout
the studies included the prevalence, incidence, and cumulative
incidence of each of P falciparum, P vivax, and any Plasmodium
species.
Excluded studies
Of the 20 full texts we screened from the literature search update,
we excluded seven articles. Six corresponded to four trials that were
not truly RCTs as they included only one cluster per arm. The
seventh article reported a trial that had an inappropriate control
group, as most participants in both groups were regularly using
ITNs.
We also excluded two trials that were included in the previous
version of the review after screening against this update’s modified
inclusion criteria. The intervention in one trial was bed nets that
were not treated with insecticide (Snow 1988), and the second
trial did not describe the measured outcomes clearly (Zaim 1998).
Further details are in the Characteristics of excluded studies table.
Characteristics of the studies excluded after the previous literature
search are described in Lengeler 2004.
Risk of bias in included studies
A detailed description of the ‘Risk of bias’ assessments against
the following criteria are provided in each included trial’s ‘Risk of
bias’ table in the ‘Characteristics of included studies’ section. A
summary is provided in the ‘Risk of bias’ summary figure (Figure
2).
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Figure 2. ‘Risk of bias’ summary: review authors’ judgements about each risk of bias item for each included
study.
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Allocation
Though each study described the distribution of clusters to inter-
vention or control arms as random, in several instances the specific
randomization and allocation concealment processes are not de-
scribed. We considered such trials to have an unclear risk of bias.
Randomization procedures, where described, typically involved a
public lottery, or a computer-generated randomization sequence.
Blinding
Due to the nature of the intervention, it is difficult to blind par-
ticipants and study personnel to the allocated intervention group,
and blinding was only conducted in five trials (Kamol-Ratanakul
1992; Luxemburger 1994; Magris 2007; Rabarison 1995; Snow
1987). However, the outcomes evaluated here, that is infection,
mortality, and morbidity from malaria, were considered unlikely
to be affected by participant knowledge of intervention status. We
therefore assumed each of the trials to be at low risk of perfor-
mance bias.
The measurement of outcomes was also considered to be unaf-
fected by intervention knowledge for mortality, severe malaria,
and prevalence of malaria as collected from cross-sectional surveys.
However, we considered that outcomes through participants’ self
reporting of fevermay be influenced by knowledge of the allocated
intervention group. If self reported cases were confirmed by mi-
croscopy or a rapid diagnostic test, we considered the risk of detec-
tion bias to be unclear. In five trials, cases were recorded solely on
the basis of self reporting, without further confirmation (Kroeger
1995 (Colombia); Kroeger 1995 (Ecuador); Kroeger 1995 (Peru
Amazon); Kroeger 1995 (Peru Coast); Kroeger 1999). We consid-
ered these trials to have a high risk of detection bias.
Incomplete outcome data
We considered one trial to be at high risk of attrition bias, as the
study participants included children aged 1 to 59 months, but
in cross-sectional surveys, only children aged 1 to 3 years were
sampled (Phillips-Howard 2003). We judged the risk of bias to be
unclear for nine trials that insufficiently reported the total numbers
randomized and reasons for attrition.
Selective reporting
All included trials had a low risk of reporting bias.
Other potential sources of bias
We considered three trials to have a high risk of bias due to sig-
nificant imbalances between intervention and control groups at
baseline for one or more reported outcomes (Fraser-Hurt 1999;
Kroeger 1995 (Colombia); Kroeger 1995 (Peru Amazon)). We
judged trials that did not adequately report on baseline differences
as at unclear risk of bias.
Effects of interventions
See: Summary of findings for the main comparison Insecticide-
treated bed nets and curtains compared to no nets for preventing
malaria; Summary of findings 2 Insecticide-treated bed nets and
curtains compared to untreated nets for preventing malaria
Comparison 1: Insecticide-treated nets versus no nets
Twelve trials assessed this comparison: nine in sub-Saharan Africa,
one in Cambodia, one in Myanmar and one in Pakistan
Child mortality from all causes
Five cRCTs reported child mortality from all causes. Four were
conducted in highly malaria endemic areas in sub-Saharan Africa,
and one newly identified trial was conducted in Myanmar
(Smithuis 2013). The latter trial was small and contributed to
0.1% of the overall weight of the analysis. Pooled analysis of five
trials showed that mortality from all causes was 17% lower in
children using an ITN than those without a net (rate ratio 0.83,
95% CI 0.77 to 0.89: 5 trials, 200,833 participants Analysis 1.1).
This corresponds to a saving of 5.6 lives (95% CI 3.6 to 7.6) each
year for every 1000 children protected with ITNs. We assessed
the mortality from all causes rate in a high-risk age group (1 to
59 months) using data from four trials (Binka 1996; Halbluetzel
1996; Nevill 1996; Phillips-Howard 2003), finding a saving of
6.4 lives (95% CI 4.16 to 8.69) for every 1000 children protected
with ITNs.
Uncomplicated clinical episodes
Five cRCTs reported the impact of ITNs on the incidence of un-
complicated P falciparum episodes. Four trials were conducted in
highlymalaria endemic areas in sub-SaharanAfrica, and one newly
identified trial was conducted in Cambodia (Sochantha 2006).
One trial, conducted in an area of known insecticide resistance
in Ivory Coast, demonstrated a rate ratio of 0.43 (95% CI 0.25
to 0.74). Overall, the reduction in the rate of clinical episodes
was almost 50% (rate ratio 0.55, 95% CI 0.48 to 0.64; 5 trials,
35,551 participants Analysis 1.2). Additionally, two trials reported
the impact of ITNs on the proportion of people experiencing a
clinical episode of P falciparum within a given time frame (cumu-
lative incidence). A similar overall reduction was seen to that of
the incidence rate (RR 0.44, 95% CI 0.31 to 0.62; 2 trials, 10,967
participants, Analysis 1.3).
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Two cRCTs, conducted in Myanmar and Pakistan respectively, re-
ported the impact of ITNs on the cumulative incidence of un-
complicated P vivax episodes. Clinical episodes of P vivaxwere re-
duced by 39% in people using an ITN (RR 0.61, 95% CI 0.48 to
0.77; 2 trials, 10,967 participants Analysis 1.4). One trial also re-
ported the cumulative incidence of uncomplicated episodes of any
Plasmodium species, finding a 50% reduction in the ITN group
(RR 0.50, CI 0.28 to 0.90; 1 trial, 8,395 participants, Analysis
1.5) (Smithuis 2013).
Prevalence
Six cRCTs reported the impact of ITNs on P falciparum preva-
lence.One newly identified study that was conducted inMyanmar
contributed 6.8% of the overall weight of the analysis (Smithuis
2013). Prevalence was reduced by 17% with ITN use (RR 0.83,
95% CI 0.71 to 0.98; 6 trials, 18,809 participants, Analysis 1.6).
Two studies, conducted in Myanmar and Pakistan respectively,
reported the impact of ITNs on the prevalence of P vivax. We
found no difference between ITN and no-nets groups (RR 1.00,
95% CI 0.75 to 1.34; 2 trials, 10,967 participants, Analysis 1.7).
Severe malaria episodes
Two trials evaluated severe malarial disease as an outcome, using
passive and hospital/health centre-based case ascertainment. Due
to the very low number of cases in Myanmar, the trial contributed
only 0.3% of the overall weight of the analysis. Pooled analysis
showed a 44%reduction in the incidence of severemalaria episodes
in the ITN group (rate ratio 0.56, 95% CI 0.38 to 0.82; 2 trials,
31,173 participants, Analysis 1.8).
Anaemia
Five trials reported the mean haemoglobin in ITN and no-nets
arms. Pooled analysis of the trials showed that ITNswere associated
with a mean difference of a 1.29 increase in percentage PCV (95%
CI 0.42 to 2.16; 5 trials, 11,489 participants, Analysis 1.9).
Comparison 2: Insecticide-treated nets versus
untreated nets
Eleven trials assessed this comparison: three in sub-Saharan Africa,
six in Latin America, and two in Thailand.
Child mortality from all causes
Two cRCTs, conducted in highly malaria endemic areas in sub-
Saharan Africa, reported child mortality from all causes. Pooled
analysis of the trials showed thatmortality from all causes was 33%
lower in children using an ITN than in those using an untreated
net, but as the CI includes no effect, the result is not statistically
significant (rate ratio 0.67, 95% CI 0.36 to 1.23; 2 trials, 25,389
participants, Analysis 2.1). This corresponds to a saving of 3.5 lives
(95% CI -2.4 to 6.8) each year for every 1000 children protected
with ITNs. The mortality from all causes rate in a high-risk age
group (1 to 59 months) was determined using data from one trial
(D’Alessandro 1995). In this group, the saving is 8.0 lives (95%
CI -5.6 to 15.57) for every 1000 children protected with ITNs.
Uncomplicated clinical episodes
Four cRCTs and one individual RCT reported the impact of ITNs
on the incidence of uncomplicated P falciparum episodes. The
overall analysis showed that ITNs contributed to a 42% reduction
in the rate of clinical episodes (rate ratio 0.58, 95% CI 0.44 to
0.78; 5 trials, 2,036 participants, Analysis 2.2).
Two cRCTs and one individual RCT, conducted in Thailand (two)
and Venezuela, reported the incidence of uncomplicated P vivax
episodes. The overall decrease in the rate of clinical episodes of
P vivax in people using an ITN was not statistically significant
(rate ratio 0.73, 95% CI 0.51 to 1.05; 3 trials, 1,535 participants,
Analysis 2.3). The reduction seen in the cumulative incidence of
uncomplicated episodes of P vivax, reported by three trials in Latin
America, was also not statistically significant (RR 0.59, CI 0.30
to 1.18; 3 trials, 23,506 participants, Analysis 2.4). Two trials
also reported the cumulative incidence of uncomplicated episodes
of any Plasmodium species, reporting a reduction that was not
statistically significant (RR 0.47, 95% CI 0.17 to 1.28, 2 trials,
8,082 participants, Analysis 2.5).
Prevalence
Two cRCTs in sub-Saharan Africa and one individual RCT in
a displaced persons camp in Thailand (accounting for 3.3% of
the overall weight of the analysis) reported the impact of ITNs
versus untreatednets onprevalence ofP falciparum. Pooled analysis
showed that the reduction in prevalence was not significant (RR
0.91, 95% CI 0.78 to 1.05; 3 trials, 2,259 participants, Analysis
2.6).
The trial conducted in Thailand also reported a reduction in P
vivax prevalence that was not statistically significant (RR 0.68,
95% CI 0.25 to 1.85; 1 trial, 350 participants, Analysis 2.7;
Luxemburger 1994), and one trial reported a massive reduction in
the prevalence of any Plasmodium species (RR 0.17, 0.05 to 0.53;
1 trial, 924 participants, Analysis 2.8; Magris 2007). However the
results are of limited value as there was only a single trial in each
analysis.
Severe malaria episodes
No trials evaluating this comparison reported the outcome of se-
vere malaria episodes.
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Anaemia
Three cRCTs reported the mean haemoglobin in ITN and un-
treated-net study arms. For two studies, information on the
mean PCV, total number sampled, and standard deviation were
all available, permitting pooling of the data in a meta-analysis
(D’Alessandro 1995; Snow 1987). Pooled analysis showed that
ITNs were associated with a mean difference of a 0.48 increase in
the percentage PCV that was not statistically significant (95% CI
-0.54 to 1.50; 2 trials, 1,909 participants, Analysis 2.9).
The third trial also reported the mean haemoglobin in both arms
over two surveys. This trial reported a variable impact of ITNs
compared to untreated nets, with a mean PCV difference of -1.2
(624 participants) in the first survey and +1.5 (516 participants)
in the second survey.
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A D D I T I O N A L S U M M A R Y O F F I N D I N G S [Explanation]
Insecticide- treated bed nets and curtains (ITNs) compared to untreated nets (UTNs) for preventing malaria
Patient or population: people of all ages living in malaria transmission sett ings
Setting: Colombia 1993 (Kroeger 1995 (Colombia)); Ecuador 1992 (Kroeger 1995 (Ecuador)); Gambia 1993 (D’Alessandro 1995); Gambia 1985 (Snow 1987); Madagascar
1994 (Rabarison 1995); Nicaragua 1996 (Kroeger 1999); Peru Amazon 1992 (Kroeger 1995 (Peru Amazon)); Peru Coast 1993 (Kroeger 1995 (Peru Coast)); Thailand 1988
(Kamol-Ratanakul 1992); Thailand 1991 (Luxemburger 1994); Venezuela 2000 (Magris 2007)
Intervention: ITNs
Comparison: UTNs
Outcomes Anticipated absolute effects∗ (95% CI) Relative effect
(95% CI)
Number of participants
(trials)
Certainty of the evi-
dence
(GRADE)
Comments
Risk with UTNs Risk with ITNs
Child mortality f rom all
causes
Children of all ages Rate rat io 0.67
(0.36 to 1.23)
25,389
(2 RCTs)
⊕⊕⊕©
MODERATEa,b
due to imprecision
Insect icide-treated bed
nets and curtains prob-
ably reduce all-cause
child mortality com-
pared to UTNs
10.6 per 1000 7.1 per 1000
(3.8 to 13.0)
Children aged 1 to 59 months
24.3 per 1000 16.3 per 1000
(8.8 to 29.9)
Plasmodium fal-
ciparum uncomplicated
episodes
289 per 1000 167 per 1000
(124 to 228)
Rate rat io 0.58
(0.44 to 0.78)
2,036
(5 RCTs)
⊕⊕⊕⊕
HIGHa,c
Insect icide-treated bed
nets and curtains re-
duce the incidence of
uncomplicated P falci-
parummalaria episodes
compared to UTNs.
Plasmodium vivax un-
complicated episodes l
143 per 1000 104 per 1000
(73 to 150)
Rate rat io 0.73
(0.51 to 1.05)
1,535
(3 RCTs)
⊕⊕©©
LOWa,b,d
due to imprecision and in-
directness
Insect icide-treated bed
nets and curtains may
reduce the incidence of
uncomplicated P vivax
1
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malaria episodes com-
pared to UTNs.
Any Plas-
modium spp. uncompli-
cated episodes (cumu-
lat ive incidence)
69 per 1000 32 per 1000
(12 to 88)
Risk rat io 0.47
(0.17 to 1.28)
8,082
(2 RCTs)
⊕⊕⊕©
MODERATEa,b,e
due to imprecision
Insect icide-treated bed
nets and curtains prob-
ably reduce the in-
cidence of uncompli-
cated malaria episodes
of any species com-
pared to UTNs
P falciparum prevalence 378 per 1000 344 per 1000
(295 to 397)
Risk rat io 0.91
(0.78 to 1.05)
2,259
(3 RCTs)
⊕⊕⊕©
MODERATEa,b
due to imprecision
Insect icide-treated bed
nets and curtains prob-
ably reduce the preva-
lence of P falciparum
malaria compared to
UTNs.
P vivax prevalence 39 per 1000 27 per 1000
(10 to 73)
Risk rat io 0.68
(0.25 to 1.85)
350
(1 RCT)
⊕©©©
VERY LOWa,f,g
due to imprecision and in-
directness
It is unclear if ITNs
reduce the prevalence
of P vivax malaria com-
pared to UTNs.
Any Plasmodium spp.
prevalence
104 per 1000 18 per 1000
(5 to 55)
Risk rat io 0.17
(0.05 to 0.53)
924
(1 RCT)
⊕©©©
VERY LOWa,h,i
due to imprecision and in-
directness
It is unclear if ITNs re-
duce the prevalence of
malaria, regardless of
species, compared to
UTNs
Anaemia (mean packed
cell volume)
32.8 33.3 (32.3 to 34.3) Mean dif ference 0.48 (-
0.54 to 1.50)
1,909
(2 RCTs)
⊕⊕©©
LOWa,j,k
due to imprecision and in-
directness
Insect icide-treated bed
nets and curtains may
increase the mean
packed cell volume
compared to UTNs
*The risk in the intervention group (and its 95%CI) is based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its 95%CI).
Abbreviations: CI: conf idence interval; RCT: randomized controlled trial; ITN: Insect icide-treated net; UTN: untreated net
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GRADE Working Group grades of evidence
High certainty: we are very conf ident that the true ef fect lies close to that of the est imate of the ef fect.
Moderate certainty: we are moderately conf ident in the ef fect est imate: the true ef fect is likely to be close to the est imate of the ef fect, but there is a possibility that it is
substant ially dif f erent.
Low certainty: our conf idence in the ef fect est imate is lim ited: the true ef fect may be substant ially dif f erent f rom the est imate of the ef fect.
Very low certainty: we have very lit t le conf idence in the ef fect est imate: the true ef fect is likely to be substant ially dif f erent f rom the est imate of ef fect
aNot downgraded for indirectness: for most included studies, it is unclear whether insect icide resistance was present. The
review authors judge that there is not convincing evidence that insect icide resistance would reduce the impact of ITNs on
the included epidemiological outcomes. A previous review that included entomological outcomes showed the dif ference in
mosquito mortality risk using ITNs compared with UTNs modest ly decreased as insect icide resistance increased (Strode
2014). However, mosquito mortality risk remained signif icant ly higher for ITNs than for UTNs, regardless of the resistance
status.
bDowngraded one level for imprecision: the conf idence interval includes both a sizable decrease and an increase in the
absolute number of events.
cNot downgraded for inconsistency: despite signif icant heterogeneity (I2 value of 75%), each trial consistent ly shows an ef fect
in favour of ITNs.
dDowngraded one level for indirectness: the three studies had restrict ive part icipant inclusion criteria. The largest weighted
study included only children f rom a displaced persons camp in Thailand. The second study included only migrant workers
also in Thailand. The third included only children younger than 10 years in Venezuela. It is not clear how conf ident ly the
information can be applied to other populat ions.
eNot downgraded for risk of bias: although the lack of part icipant blinding could potent ially inf luence the likelihood of report ing
a fever, we did not consider this likely to have seriously af fected the results of the studies.
fDowngraded two levels for imprecision: the conf idence interval includes both a sizable decrease and increase in the absolute
number of events. Addit ionally, the small sample size and low number of events are insuf f icient for conf ident ly est imating the
ef fect size.
gDowngraded two levels for indirectness: the results come f rom only one study, conducted only in children living in displaced
persons camps in Thailand. It is not clear how conf ident ly the information can be applied to other populat ions.
hDowngraded one level for imprecision: the small sample size and low number of events are insuf f icient for conf ident ly
est imating the ef fect.
iDowngraded two levels for indirectness: the results come f rom only one study, conducted only in children living in the
Amazon rainforest. It is not clear how conf ident ly the information can be applied to other populat ions.
jDowngraded one level for indirectness: the results come f rom two studies that were both conducted in Gambia and only
included children under the age of 10. It is not clear how conf ident ly the information can be applied to other populat ions.
kDowngraded one level for imprecision: the conf idence interval includes both a decrease and increase in the mean packed
cell volume.
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lThe cumulat ive incidence of P vivax clinical episodes was also reported (Analysis 2.4: RR 0.58, 95% CI 0.30 to 1.14, low-
certainty evidence). As this is consistent with the ef fect on the incidence rate, we did not present both results in the ‘Summary
of f indings’ table.
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D I S C U S S I O N
Summary of main results
We identified three new trials for inclusion that have been pub-
lished since the previous version of this review (Lengeler 2004).
The new trials did not affect the conclusions of our review. Each
reported outcome showed a trend that favoured ITNs, both in
comparison to no nets (see Summary of findings for the main
comparison) and untreated nets (see Summary of findings 2). In-
secticide-treatednetswere shown to reduce childmortality fromall
causes by almost one-fifth compared to children sleepingwithout a
net (high-certainty evidence). Uncomplicated clinical episodes of
malaria were reduced by almost one-half (high-certainty evidence)
and severe malaria episodes were also reduced by more than 40%
(high-certainty evidence). The prevalence ofP falciparum was re-
duced by 17% (high-certainty evidence), although a pooled anal-
ysis of two trials showed no impact on prevalence of P vivax (low-
certainty evidence). We found similar results when ITNs were
compared to untreated nets, with child mortality from all causes
reduced by one-third (moderate-certainty evidence). Uncompli-
cated clinical episodes of P falciparum and P vivaxwere reduced by
42% (high-certainty evidence) and 27% (low-certainty evidence),
respectively. Reductions in the prevalence of P falciparum and P
vivax were not significant (moderate- and very low certainty evi-
dence).
Overall completeness and applicability of
evidence
Although publishedmore recently than the studies included in the
previous review, two of the newly included studies were conducted
in the year 2000 (Magris 2007; Smithuis 2013), and the third was
conducted in 2001 (Sochantha 2006). Each of the new studies
was therefore conducted no later than the date of publication of
the previous review, and consequently the additional insight they
can provide into the effectiveness of ITNs today, in the presence
of widespread insecticide resistance, is limited. For most of the
included studies, it was unclear whether insecticide resistance was
present. However, one included study was specifically conducted
in an area of known high insecticide resistance (Henry 2005). Al-
though the study was carried out between July 1999 and June
2000, local populations of Anopheles gambiae s.s. were strongly re-
sistant to pyrethroids, with a knockdown resistance (kdr) allelic
frequency of around 90%. Anopheles funestus, another local pri-
mary vector, was still susceptible to these insecticides. The impact
on P falciparum uncomplicated episodes was the only reported
outcome eligible for inclusion in this review, showing a reduction
in the rate of clinical episodes in the ITN group of 57%. This was
in fact the greatest impact reported by any study for this outcome.
Hence the study provides no evidence that ITNs became less ef-
fective in the presence of high kdr frequency.
Certainty of the evidence
We found no convincing evidence, either in this review or in the
currently available literature, that insecticide resistance would sig-
nificantly affect the impact of ITNs on the epidemiological out-
comes reported here. A previous review that included entomolog-
ical outcomes showed that the difference between mosquito mor-
tality risk using ITNs compared with use of untreated nets de-
creased modestly as insecticide resistance increased (Strode 2014).
However, mosquito mortality risk remained significantly higher
for ITNs than for untreated nets, regardless of the resistance status.
Additionally, despite reports of moderate-to-high pyrethroid re-
sistance across many endemic countries, the distribution of ITNs
continues to impact on malaria incidence and prevalence (Alout
2017). Until there is evidence that insecticide resistance is reduc-
ing the impact of ITNs on epidemiological outcomes, we adjudge
that we should not decrease our certainty in the estimate of the
effect of ITNs based on the presence of insecticide resistance. A
full assessment of the certainty of the evidence for each outcome
is presented in the ‘Summary of findings’ tables.
Potential biases in the review process
If included cRCTs did not adjust for clustering in the analysis, we
adjusted the data before it was combined. A potential bias arises
for trials that did not report the ICC value, for which we used the
ICC from a similar trial that reported the same outcome (Smithuis
2013). This approximated ICC value may lead to somewhat in-
accurate sizes of CIs for such trials, although the estimate of the
effect would not be affected.
Agreements and disagreements with other
studies or reviews
Despite being published before most trials included in this review
were conducted, Choi 1995’s meta-analysis reported a similar im-
pact of ITNs on the incidence of malaria infection. In comparison
to participants receiving no nets, the incidence was reduced by
51%. In the subset of trials comparing ITNs to UTNs, a smaller,
but still significant, reduction of 24% was seen. More recently,
Yang 2018 conducted a meta-regression of 39 studies published
since the year 2000. The review differentiated classic ITNs, which
require re-treating at least once per year, from long-lasting insec-
ticide-treated nets (LLINs), which use newer fabric technologies
to remain effective for several years. The meta-regression found
that ITNs and LLINs respectively reduce the incidence of malaria
by 41% and 56% when compared to no nets. Though no other
outcomes were assessed in either study, the finding supports the
21Insecticide-treated nets for preventing malaria (Review)
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suggestion that treated nets have remained effective at preventing
malaria cases in recent decades, despite growing concerns about
insecticide resistance in malaria vectors. Unlike this review, both
Choi 1995 and Yang 2018 included field trials of any study de-
sign, as long as they had a concurrent control group. Importantly,
the reviews did not consider that cRCTs cannot be analysed with
the same methods used when interventions are allocated on an
individual level. The confidence limits presented in these reviews
may therefore be deceptive. The more conservative confidence in-
tervals presented in this review, calculated in line with the design
effect of the studies, provide a more dependable indication of the
lowest and largest possible effect sizes.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Despite the increase in insecticide resistance frequency and inten-
sity in populations of malaria vectors across the world, the evi-
dence for the effectiveness of ITNs for reducing malaria-related
illness and death remains strong.
Implications for research
Although we judge that there is currently no strong evidence that
insecticide resistance is reducing the impact of ITNs on epidemi-
ological outcomes, future research should continue to concentrate
onmonitoring the spread of insecticide resistance and understand-
ing if there is a relationship between observed resistance and re-
duced effectiveness of insecticide-based vector control interven-
tions.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Binka 1996
Methods Study design: cluster RCT (cRCT)
Unit of allocation: clusters of compounds (average 120 compounds and 1400 people/
cluster)
Number of units: 48:48
Length of follow-up: 2 years (July 1993 to June 1995).
Outcome assessment: mortality was monitored by village reporters in addition to demo-
graphic data collected every 3 months by rolling census.
Adjustment: confidence limits for the rate ratio were calculated taking into account the
cluster randomization
Participants Number of participants: approximately 134,400
Inclusion criteria: children < 10 years
Interventions Intervention: bed net
Insecticide and dosage: permethrin suspension (0.5 g/mL)
Retreatment: every 6 months
Usage: year 1: 97% July-Dec, 65% Jan-June; year 2: 72% July-Dec, 50% Jan-June
Control: no net
Outcomes Outcomes measured: mortality rate
Notes Study location: Kassena-Nankana district, Ghana
EIR: 100 to 1000
Malaria transmission: variable but high
Main vectors: Anopheles gambiae s.s.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Open lotteries were conducted during 21
community meetings to randomly select
the clusters that were to receive the impreg-
nated bed nets
Allocation concealment (selection bias) Low risk Open lottery conducted.
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Not possible to blind participants and per-
sonnel, but this was not likely to introduce
bias to the outcome of mortality
Blinding of outcome assessment (detection
bias)
Self-reported fever
Low risk This outcome was not assessed.
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Binka 1996 (Continued)
Blinding of outcome assessment (detection
bias)
All other outcomes
Low risk Not possible to blind outcome assessors,
but this was not likely to introduce bias
when measuring the outcome of mortality
Incomplete outcome data (attrition bias)
All outcomes
Low risk High estimated sensitivity to all deaths in
the study area
Selective reporting (reporting bias) Low risk All expected outcomes reported.
Other bias Low risk Recruitment bias: low risk
Baseline imbalance: the pre-intervention
mortality rates were comparable (23.0 and
23.5/1000 child years in the treated and
control clusters respectively)
Loss of clusters: none
Incorrect analysis: adjusted
Comparability with RCTs randomizing in-
dividuals: suitable due to cluster-adjusted
confidence intervals (CIs)
D’Alessandro 1995
Methods Study design: cRCT
Unit of allocation: village (52 pairs of villages formed on the basis of size, after stratifi-
cation by 5 geographical areas)
Number of units: 58:52
Length of follow-up: 12 months
Dropout rate unknown, but immigration/emigration rates were low (< 5% per year)
Mortality monitored by village reporters and yearly census. Morbidity surveys were
conducted once, at the peak of the transmission season in October (n = 1520 in 50
villages). All surveys were community-based
Participants Inclusion criteria: children aged 0 to 9 years and living in the area were eligible at the
start, but the analysis was later restricted to children aged 1 to 59 months (n = 25,000)
Exclusion criteria: no explicit exclusion criteria except absence of written consent
Interventions Intervention: treatment of existing bed nets in the frame of a national programme;
target dose 200 mg/m2 permethrin; impregnation done by village health workers with
the assistance of other community members and under the supervision of community
health nurses; retreatment was not done during the 1-year follow-up period since the
transmission season lasts only about 4 months
Control: untreated bed nets
Usage rate around 70% in both intervention and control areas (varied between 50% and
90% according to the area)
Outcomes • Overall mortality (1 to 59 months)
• Prevalence of parasitaemia (any)
• Prevalence of high parasitaemia (> 5000 trophozoites/µL)
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D’Alessandro 1995 (Continued)
• Anaemia (mean packed cell volume)
• Prevalence of splenomegaly (1 to 5 Hackett)
• Impact on nutritional status (weight-for-age, weight-for-height)
Notes Study location: 5 distinct areas spread over the whole of the Gambia (all rural areas)
EIR: 1 to 10
Malaria endemicity: hyperendemic
Baseline parasite rate in children 12 to 59 months: 39%
Main vector: Anopheles gambiae s.l.
P vivax malaria: very low; not taken into account for analysis
Access to health care moderately easy.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Intervention allocation by public lottery
(information provided by CL)
Allocation concealment (selection bias) Low risk Low risk given the above intervention allo-
cation procedure
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk No blinding described, but the review au-
thors judge that the outcomes of mortality
and malaria infection were unlikely to be
influenced by the lack of blinding to par-
ticipants and personnel
Blinding of outcome assessment (detection
bias)
Self-reported fever
Low risk This outcome was not assessed.
Blinding of outcome assessment (detection
bias)
All other outcomes
Low risk No blinding of outcome assessors de-
scribed, but this was unlikely to influence
the outcome measurement for mortality or
parasite prevalence
Incomplete outcome data (attrition bias)
All outcomes
Low risk No missing outcome data
Selective reporting (reporting bias) Low risk All expected outcomes reported.
Other bias Low risk Recruitment bias: low risk
Baseline imbalance: the pre-intervention
mortality rates were adjusted for in the
analysis
Loss of clusters: none
Incorrect analysis: adjusted
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D’Alessandro 1995 (Continued)
Comparability with RCTs randomizing in-
dividuals: unclear
Fraser-Hurt 1999
Methods Study design: individual RCT
Unit of allocation: individual
Number of units: 122
Length of follow-up: 6 months
Outcome assessment:monthly cross-sectional surveyswere conducted.Thick bloodfilms
were prepared at enrolment and at each survey
Participants Number of participants: 122
Inclusion criteria: children aged 5 to 24 months who were afebrile, not using a bed net,
and not taking chloroquine
Interventions Type of intervention: bed net (n = 61)
Insecticide and dosage: permethrin (500 mg/m2)
Retreatment: after 3 months and at the end of the trial
Usage: 97%
Control: no net (n = 61)
Outcomes Outcomes measured: P falciparum prevalence
Notes Study location: Kiberege, Kilombero District, southern Tanzania
EIR: approximately 300
Malaria transmission: intense and perennial
Main vectors: Anopheles gambiae s.l. and Anopheles funestus
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Individuals allocated randomly, but the
randomization process is not described
Allocation concealment (selection bias) Unclear risk Not described
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Participants and personnel were not
blinded to intervention group, but the re-
view authors judge that this was unlikely to
impact on the outcome of prevalence
Blinding of outcome assessment (detection
bias)
Self-reported fever
Low risk This outcome is not assessed.
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Fraser-Hurt 1999 (Continued)
Blinding of outcome assessment (detection
bias)
All other outcomes
Low risk Outcome assessors not blinded, but all
participants were surveyed using objective
blood smear examination, so this was un-
likely to introduce bias
Incomplete outcome data (attrition bias)
All outcomes
Low risk Missing outcome data very minimal and
balanced in numbers across the interven-
tion groups (1 from each)
Selective reporting (reporting bias) Low risk All expected outcomes reported.
Other bias High risk Recruitment bias: low risk
Baseline imbalance: the pre-intervention
prevalence was substantially different be-
tween the intervention group (54.1%) and
control group (65%)
Halbluetzel 1996
Methods Study design: cRCT
Unit of allocation: groups of villages (8 pairs of “clusters” (on average 10 villages) formed
on the basis of baseline mortality and geographic similarity)
Number of units: 8:8
Length of follow-up: 24 months
Mortality was monitored by village reporters and yearly census. A cross-sectional mor-
bidity survey was conducted once, at the peak of the transmission season in September
1995 (n = 800 in 84 villages). All surveys were community-based
Participants Number of participants: 16,540
Inclusion criteria: children aged 0 to 59 months living in the area (newborns were
excluded from the analysis)
Exclusion criteria: no explicit exclusion criteria except absence of written consent
Interventions Intervention: permethrin-treated curtains on windows, door, and eaves; target dose of
1000 mg/m2; every house used for sleeping in the intervention clusters fitted with the
curtains and retreated every 6 months
Control: no curtains
Outcomes • Overall mortality (1 to 59 months)
• Prevalence of parasitaemia (any)
• Prevalence of high parasitaemia (> 5000 trophozoites/µL)
• Anaemia (mean haemoglobin in g/dL)
Notes Study location: Oubritenga Province, 30 km north of Ouagadougou, Burkina Faso, in
a rural area
EIR: 300 to 500
Malaria endemicity: holoendemic
Baseline parasite rate in children aged 6 to 59 months: 85%
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Halbluetzel 1996 (Continued)
Main vectors: Anopheles gambiae s.l. and Anopheles funestus
P vivax malaria: 0%
Dropout rate unknown, but immigration/emigration rates were low (2% per year)
Access to health care considered poor.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Intervention allocation by public lottery
(information provided by CL)
Allocation concealment (selection bias) Low risk Low risk given the above intervention allo-
cation procedure
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Not possible to blind participants and per-
sonnel, but the review authors do not con-
sider this likely to introduce bias for the
outcome of mortality
Blinding of outcome assessment (detection
bias)
Self-reported fever
Low risk This outcome was not assessed.
Blinding of outcome assessment (detection
bias)
All other outcomes
Low risk No blinding, but the review authors judge
that the outcome and the outcome mea-
surement were not likely to be influenced
by lack of blinding
Incomplete outcome data (attrition bias)
All outcomes
Low risk High estimated sensitivity to all deaths in
the study area
Selective reporting (reporting bias) Low risk All expected outcomes reported.
Other bias Low risk Recruitment bias: low risk
Baseline imbalance: the pre-intervention
mortality rates were adjusted for
Loss of clusters: none
Incorrect analysis: adjusted
Comparability with RCTs randomizing in-
dividuals: suitable with adjusted CIs
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Henry 2005
Methods Study design: cRCT
Unit of allocation: village (allocation of 8 villages by paired randomization)
Number of units: 4:4
Length of follow-up: 12 months
Outcome assessment: active case surveillance by repeated cross-sectional surveys. Blood
smear taken from every sick child, as assessed by nurse visit. Generalized estimating
equation (GEE) applied for clustered data
Participants Number of participants: 426
Inclusion criteria: children aged 0 to 59 months
Interventions Intervention: bed net (n = 210)
Insecticide and dosage: lambda-cyhalothrin formulated as a capsule suspension (15 mg
a.i./m2)
Retreatment: nets dipped again after 6 months.
Usage: average coverage rate with ITNs ranged from76.7% to 84.0% in different villages.
Control: no net (n = 216)
Outcomes Outcomes measured: cumulative incidence of uncomplicated episodes
Notes Study location: Korhogo, in the North of Côte d’Ivoire. High knockdown resistance
(kdr) resistance
EIR: 55
Malaria transmission: baseline prevalence of 82% in 1997 before implementation
Main vectors: Anopheles gambiae s.s. and Anopheles funestus. A gambiae was strongly
resistant to pyrethroids with a kdr allelic frequency of around 90%. A funestus was still
susceptible to these insecticides.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk It is stated that the village chosen from each
matched pair to receive ITN was randomly
selected, but no details provided
Allocation concealment (selection bias) Unclear risk No information provided.
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Not possible to blind participants and per-
sonnel, but this was not likely to introduce
bias to the outcome of malaria infection
Blinding of outcome assessment (detection
bias)
Self-reported fever
Unclear risk Nurse examining and recording cases of
sickness at the homewouldhave been aware
of study group being visited. Unclear if
technicians examining blood slides were
blinded to the study group
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Henry 2005 (Continued)
Blinding of outcome assessment (detection
bias)
All other outcomes
Low risk These outcomes were not assessed.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Missing outcome data were balanced across
the intervention groups. Reasons for miss-
ing data given, but only as a total and not
for each intervention group, possiblymask-
ing biases (58 total deaths). An imbalance
between the groups may have introduced
bias to the examined outcomes
Selective reporting (reporting bias) Low risk All stated outcomes reported.
Other bias Low risk Recruitment bias: low risk
Baseline imbalance: baseline figures com-
parable for prevalence (P = 0.35) and inci-
dence (P = 0.36)
Loss of clusters: none
Incorrect analysis: adjusted
Comparability with RCTs randomizing in-
dividuals: suitable for comparison
Kamol-Ratanakul 1992
Methods Study design: cRCT
Unit of allocation: household (average 4.8 per household) stratified bymalaria endemicity
Number of units: 26:28
Length of follow-up: 8 months (November 1987 to July 1988)
Outcome assessment: morbidity rates monitored longitudinally by weekly follow-up, at
which blood slides were taken systematically
Participants Number of participants: 261
Inclusion criteria: migrant workers who had migrated to the study area more than 6
months prior to interview
Interventions Intervention: bed net (n = 126)
Insecticide and dosage: permethrin; 500 mg/m2
Retreatment: not stated
Usage: compliance 70% to 80%
Control: untreated net (n = 135) compliance 70% to 80%
Outcomes Outcomes measured: incidence of clinical episodes for both P falciparum and P vivax
Notes Study location: Bothong District, Chonburi, Thailand
EIR: low
Malaria transmission: unstable
Main vectors:
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Kamol-Ratanakul 1992 (Continued)
Anopheles dirus
% P vivax cases: 43%; analysed separately
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Randomization scheme stated but not de-
scribed.
Allocation concealment (selection bias) Low risk 1 investigator who was not otherwise in-
volved in the care or evaluation of partici-
pants prepared the randomization
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Participants were blinded to treated or un-
treated net.
Blinding of outcome assessment (detection
bias)
Self-reported fever
Low risk Participants and outcome assessors were
blinded to treated or untreated net
Blinding of outcome assessment (detection
bias)
All other outcomes
Low risk Outcome assessors were blinded to treated
or untreated net.
Incomplete outcome data (attrition bias)
All outcomes
Low risk All randomized participants included in
follow-up.
Selective reporting (reporting bias) Low risk All expected outcomes reported.
Other bias Low risk Recruitment bias: low risk
Baseline imbalance: the pre-intervention
history of malaria in each group did not
differ significantly
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Kroeger 1995 (Colombia)
Methods Study design: cRCT
Unit of allocation: village (22 villages were paired according to size, geographic location,
net coverage, and malaria incidence at baseline; 1 village within each pair was then
randomized to receive the intervention)
Number of units: 11:11
Length of follow-up: 12 months (February 1993 to February 1994)
Outcome assessment: cross-sectional survey carried out during the peak of the malaria
season at baseline and 1 year post-intervention.
Adjustment: none
Participants Number of participants: 5632
Inclusion criteria: all inhabitants of the study area. % children under 15 = 50.6%
Interventions Intervention: community programme for sales and promotion of bed nets, and free net
treatment (n = 2295)
Insecticide and dosage: lambda-cyhalothrin treatment of existing bed nets; target dose
10 to 30 mg/m2
Retreatment: not stated
Usage: nearly 60% of all existing nets were treated at least once
Control: untreated net (n = 2337). Usage was very high (96% coverage)
Outcomes Outcomes measured: period-prevalence (last 2 weeks or last 4 months) of reported
“malaria episodes” assessed during the peak of the malaria season (February to March)
Although no systematic parasitological confirmation was done, quality control proce-
dures ensured adequate accuracy. (According to a pilot phase, about 88% to 96% of the
self diagnoses were based on the same criteria as health professionals. In addition, time
trends were compared to those obtained from routine data.)
Notes Study location: lowerRio San Juan,DepartamenteChoco on the PacificCoast, Colombia
EIR: < 1
Malaria transmission: hypoendemic and unstable with marked seasonal variation
Main vectors: Anopheles nevai
% P vivax cases: < 41.5%
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk It was stated that villages were paired
and randomly allocated, but randomiza-
tion programme is not described
Allocation concealment (selection bias) Unclear risk Allocation concealment not described.
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Not possible to blind participants and per-
sonnel, but the review authors judge that
this lack of blinding was unlikely to have
affected the outcome of malaria infection
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Kroeger 1995 (Colombia) (Continued)
Blinding of outcome assessment (detection
bias)
Self-reported fever
High risk As participants were not blinded, this may
introduce bias for the outcome measure-
ment, particularly as the reporting of cases
is subject to participants self reporting and
recalling over a 4-month period
Blinding of outcome assessment (detection
bias)
All other outcomes
Low risk These outcomes were not assessed.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Insufficient reporting of attrition to permit
judgement
Selective reporting (reporting bias) Low risk Outcomes reported are those expected, as
they are in line with a series of trials con-
ducted by the same authors across South
America
Other bias High risk Recruitment bias: low risk
Baseline imbalance: 4-month incidence
rate significantly lower in intervention
group
Loss of clusters: none
Incorrect analysis: no adjustment to CIs to
account for clustering
Comparability with RCTs randomizing in-
dividuals: not comparable unless clustering
is adjusted for by review authors
Kroeger 1995 (Ecuador)
Methods Study design: cRCT
Unit of allocation: village (14 villages were paired according to size, geographic location,
net coverage, and malaria incidence at baseline; 1 village within each pair was then
randomized to receive the intervention)
Number of units: 7:7
Length of follow-up: 12 months (March 1993 to March 1994)
Outcome assessment: cross-sectional survey carried out during the peak of the malaria
season at baseline and 1 year postintervention.
Adjustment: none
Participants Number of participants: 2450
Inclusion criteria: all inhabitants of the study area. % children under 15 = 51.6%
Interventions Intervention: community programme for sales and promotion of bed nets, and free net
treatment (n = 1418)
Insecticide and dosage: permethrin treatment of existing bed nets; target dose 200 mg/
m2
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Kroeger 1995 (Ecuador) (Continued)
Retreatment: not stated
Usage: nearly 80% of all existing nets were treated at least once.
Control: untreated net (n = 1032). Usage was very high (> 90% coverage)
Outcomes Outcomes measured: period-prevalence (last 2 weeks or last 4 months) of reported
“malaria episodes” assessed during the peak of the malaria season (March to April)
Outcome measures were similar to Kroeger 1995 (Colombia).
Notes Study location: Canton Muisne, on the northern coast of Ecuador
EIR: < 1
Malaria transmission: hypoendemic and unstable with marked seasonal variation
Main vectors: Anopheles albimanus
% P vivax cases: 51%
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk It was stated that villages were paired
and randomly allocated, but randomiza-
tion programme is not described
Allocation concealment (selection bias) Unclear risk Allocation concealment not described.
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Not possible to blind participants and per-
sonnel, but the review authors judge that
this lack of blinding was unlikely to have
affected the outcome of malaria infection
Blinding of outcome assessment (detection
bias)
Self-reported fever
High risk As participants were not blinded, this may
introduce bias for the outcome measure-
ment, particularly as the reporting of cases
is subject to participants self reporting and
recalling over a 4-month period
Blinding of outcome assessment (detection
bias)
All other outcomes
Low risk These outcomes were not assessed.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Insufficient reporting of attrition to permit
judgement
Selective reporting (reporting bias) Low risk Outcomes reported are those expected, as
they are in line with a series of trials con-
ducted by the same authors across South
America
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Kroeger 1995 (Ecuador) (Continued)
Other bias Low risk Recruitment bias: low risk
Baseline imbalance: no significant variation
in incidence rate at baseline
Loss of clusters: none
Incorrect analysis: no adjustment to CIs to
account for clustering
Comparability with RCTs randomizing in-
dividuals: not comparable unless clustering
is adjusted for by review authors
Kroeger 1995 (Peru Amazon)
Methods Study design: cRCT
Unit of allocation: village (36 villages were paired according to size, geographic location,
net coverage, and malaria incidence at baseline; 1 village within each pair was then
randomized to receive the intervention)
Number of units: 18:18
Length of follow-up: 12 months (April 1991 to April 1992)
Outcome assessment: cross-sectional survey carried out during the peak of the malaria
season at baseline and 1 year postintervention
Participants Number of participants: 5709
Inclusion criteria: all inhabitants of the study area. % children under 15 = 44.9%
Interventions Intervention: community programme for free net treatment (n = 2993); sales not nec-
essary as usage was already very high
Insecticide and dosage: permethrin treatment of existing bed nets; target dose 200 mg/
m2
Retreatment: not stated
Usage: nearly 61% of all existing nets treated at least once.
Control: untreated net (n = 2716). Usage was very high (95% coverage)
Outcomes Outcomes measured: period-prevalence (last 2 weeks or last 4 months) of reported
“malaria episodes” assessed during April
Outcome measures were similar to Kroeger 1995 (Colombia).
Notes Study location: Tambopata District, Madre deDios Department in the Amazonas region
of Peru
EIR: < 1
Malaria transmission: hypoendemic, little seasonality
Main vectors: Anopheles nuneztovari and Anopheles rangeli
% P vivax cases: 100%
Risk of bias
Bias Authors’ judgement Support for judgement
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Kroeger 1995 (Peru Amazon) (Continued)
Random sequence generation (selection
bias)
Unclear risk It was stated that villages were paired
and randomly allocated, but randomiza-
tion programme is not described
Allocation concealment (selection bias) Unclear risk Allocation concealment not described.
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Not possible to blind participants and per-
sonnel, but the review authors judge that
this lack of blinding was unlikely to have
affected the outcome of malaria infection
Blinding of outcome assessment (detection
bias)
Self-reported fever
High risk As participants were not blinded, this may
introduce bias for the outcome measure-
ment, particularly as the reporting of cases
is subject to participants self reporting and
recalling over a 4-month period
Blinding of outcome assessment (detection
bias)
All other outcomes
Low risk Other outcomes were not assessed.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Insufficient reporting of number random-
ized or reasons for attrition topermit judge-
ment
Selective reporting (reporting bias) Low risk Outcomes reported are those expected, as
they are in line with a series of trials con-
ducted by the same authors across South
America
Other bias High risk Recruitment bias: low risk
Baseline imbalance: incidence rate was sig-
nificantly higher in the intervention group
at baseline
Loss of clusters: none
Incorrect analysis: no adjustment to CIs to
account for clustering
Comparability with RCTs randomizing in-
dividuals: not comparable unless clustering
is adjusted for by review authors
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Kroeger 1995 (Peru Coast)
Methods Study design: cRCT
Unit of allocation: village (12 villages were paired according to size, geographic location,
net coverage, and malaria incidence at baseline; 1 village within each pair was then
randomized to receive the intervention)
Number of units: 6:6
Length of follow-up: 2 years (June 1991 to June 1993)
Outcome assessment: cross-sectional survey carried out during the peak of the malaria
season at baseline, 1 year postintervention, and 2 years postintervention
Participants Number of participants: 6941 year 1; 6810 year 2
Inclusion criteria: all inhabitants of the study area. % children under 15 = 44.3%
Interventions Intervention: community programme for sales and promotion of bed nets, and free net
treatment (n = 2859)
Insecticide and dosage: lambda-cyhalothrin treatment of existing bed nets; target dose
10 to 30 mg/m2 for the first year and permethrin (500 mg/m2) for the second year
Retreatment: not stated
Usage: nearly 60% of all existing nets were treated at least once.
Control: untreated net (n = 4082). Usage was very high (96% coverage)
Outcomes Outcomes measured: period-prevalence (last 2 weeks or last 4 months) of reported
“malaria episodes” assessed during the peak of the malaria season (June to July)
Outcome measures were similar to Kroeger 1995 (Colombia).
Notes Study location: Communidad de Catacaos, Piura Department, northern Peru on the
Pacific Coast
EIR: < 1
Malaria transmission: hypoendemic and unstable with marked seasonal variation
Main vectors: Anopheles albimanus
% P vivax cases: 100%
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk It was stated that villages were paired
and randomly allocated, but randomiza-
tion programme is not described
Allocation concealment (selection bias) Unclear risk Allocation concealment not described.
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Not possible to blind participants and per-
sonnel, but the review authors judge that
this lack of blinding was unlikely to have
affected the outcome of malaria infection
Blinding of outcome assessment (detection
bias)
Self-reported fever
High risk As participants were not blinded, this may
introduce bias for the outcome measure-
ment, particularly as the reporting of cases
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Kroeger 1995 (Peru Coast) (Continued)
is subject to participants self reporting and
recalling over a 4-month period
Blinding of outcome assessment (detection
bias)
All other outcomes
Low risk Other outcomes were not assessed.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Insufficient reporting of number random-
ized or reasons for attrition topermit judge-
ment
Selective reporting (reporting bias) Low risk Outcomes reported are those expected, as
they are in line with a series of trials con-
ducted by the same authors across South
America
Other bias Low risk Recruitment bias: low risk
Baseline imbalance: no significant differ-
ence in incidence rate between intervention
groups at baseline
Loss of clusters: none
Incorrect analysis: no adjustment to CIs to
account for clustering
Comparability with RCTs randomizing in-
dividuals: not comparable unless clustering
is adjusted for by review authors
Kroeger 1999
Methods Study design: cRCT
Unit of allocation: village. 12 communities were paired according to size, net coverage,
socio-economic characteristics, and malaria incidence at baseline; 1 village within each
pair was then randomized to receive the intervention. For the second year, 26 commu-
nities (13 pairs) were added to the trial.
Number of units: 19:19 (only 10 pairs of clusters were used for the review analysis as
the remaining 9 clusters had ITN coverage < 31% in intervention groups)
Length of follow-up: 12 months (postintervention study conducted in 1995 for initial
6 pairs and 1996 for following pairs)
Outcome assessment: cross-sectional survey carried out during the peak of the malaria
season at baseline and 1 year postintervention
Participants Number of participants: 5041:5815
Inclusion criteria: all inhabitants of the study area
Interventions Intervention: community programme for sales and promotion of bed nets, and free net
treatment (n = 5041)
Insecticide and dosage: lambda-cyhalothrin treatment of existing bed nets; target dose
12.5 mg/m2
Retreatment: not stated
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Kroeger 1999 (Continued)
Usage: 31% to 70% of individuals used an impregnated net.
Control: untreated net (n = 5815)
Outcomes Outcomes measured: period-prevalence (last 4 months) of reported “malaria episodes”
assessed during the peak of the malaria season (March to April)
Outcome measures were similar to Kroeger 1995 (Colombia).
Notes Study location: El Viejo Municipio, Department of Chinandega, North East Nicaragua
(Pacific Coast)
EIR: < 1
Malaria endemicity: hypoendemic
Baseline parasite rate in the whole population: 8%
Main vector: Anopheles albimanus
P vivax malaria: 99%
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Villages were randomly assigned using ran-
dom numbers.
Allocation concealment (selection bias) Unclear risk Allocation concealment not described.
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Not possible to blind participants and per-
sonnel, but the review authors judge that
this lack of blinding was unlikely to have
affected the outcome of malaria infection
Blinding of outcome assessment (detection
bias)
Self-reported fever
High risk As participants were not blinded, this may
introduce bias for the outcome measure-
ment, particularly as the reporting of cases
is subject to participants self reporting and
recalling over a 4-month period
Blinding of outcome assessment (detection
bias)
All other outcomes
Low risk Other outcomes were not assessed.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Insufficient reporting of number random-
ized or reasons for attrition topermit judge-
ment
Selective reporting (reporting bias) Low risk Outcomes reported are those expected, as
they are in line with a series of trials con-
ducted by the same authors across South
America
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Kroeger 1999 (Continued)
Other bias Low risk Recruitment bias: low risk
Baseline imbalance: no significant variation
in incidence rate at baseline
Loss of clusters: none
Incorrect analysis: no adjustment to CIs to
account for clustering
Comparability with RCTs randomizing in-
dividuals: not comparable unless clustering
is adjusted for by review authors
Luxemburger 1994
Methods Study design: individual RCT
Unit of allocation: individual (1 child per household)
Number of units: 175:175
Length of follow-up: 6 months (August 1990 to February 1991)
Outcome assessment: passive surveillance system through camp clinics and 2 cross-
sectional surveys, one after 3 months and one after 6 months at the end of the study,
following the peak of the transmission season
Participants Number of participants: 350
Inclusion criteria: children aged 5 to 14 years in the displaced persons camp. Children
living too far from the schools in other small camps were excluded
Interventions Intervention: bed net (n = 175)
Insecticide and dosage: permethrin (500 mg/m2)
Retreatment: not stated
Usage: 93% children under net, with 78% used correctly
Control: untreated net (n = 175) compliance similar to intervention group. The propor-
tion of households in the village that possessed impregnated nets at baseline was about
22%
Outcomes Outcomes measured:
• Incidence of clinical episodes for both P falciparum and P vivax
• Prevalence of any parasitaemia
Notes Study location: Shoklo, largest camp for Karen displaced persons on the Thai-Burmese
border
EIR: low
Malaria transmission: unstable
Main vectors: Anopheles dirus andAnopheles minimus (likely main vectors)
% P vivax cases: 20%; 10% mixed - analysed separately
Risk of bias
Bias Authors’ judgement Support for judgement
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Luxemburger 1994 (Continued)
Random sequence generation (selection
bias)
Low risk Randomization using random numbers ta-
ble
Allocation concealment (selection bias) Unclear risk Allocation concealment process not de-
scribed.
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Participants were blinded to treated or un-
treated net.
Blinding of outcome assessment (detection
bias)
Self-reported fever
Low risk Participants and outcome assessors were
blinded to treated or untreated net
Blinding of outcome assessment (detection
bias)
All other outcomes
Low risk Outcome assessors were blinded to treated
or untreated net.
Incomplete outcome data (attrition bias)
All outcomes
Low risk Loss of participants due to children leaving
the camp; numbers were balanced across
the intervention groups
Selective reporting (reporting bias) Low risk All expected outcomes reported.
Other bias Low risk Recruitment bias: low risk
Baseline imbalance: all children participat-
ing in the study were given a treatment be-
fore the beginning of the trial
Magris 2007
Methods Study design: cRCT
Unit of allocation: village (paired)
Number of units: 9:9
Length of follow-up: 2 years
Outcome assessment: continuous active (fortnightly blood smears of all villagers with
fever in last 48 hours) and passive (local health centre) case detection was carried out. 2
cross-sectional surveys carried out after intervention (6 months and 2 years) to measure
prevalence.
Adjustment: adjusted rate ratio and CIs calculated to account for randomization by
cluster and to adjust for potential confounding factors including age and sex
Participants Number of participants: 924
Inclusion criteria: children under 10
Interventions Intervention: insecticide-treated hammock net (n = 429)
Insecticide and dosage: lambda-cyhalothrin (10 mg/m2)
Retreatment: every 6 months
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Usage: not stated
Control: placebo-treated hammock net (n = 495)
Outcomes Outcomes measured:
• Malaria prevalence
• Malaria incidence
Notes Study location: Amazon rainforest, Venezuela
EIR: not stated
Malaria transmission: predominantly low with pockets of intense transmission
Main vectors: Anopheles darlingi
% P vivax cases: not stated
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk 1 village in each pair was assigned at ran-
dom by tossing a coin to the intervention
or the control
Allocation concealment (selection bias) Low risk Low risk for bias with the above random-
ization procedure
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Participants were blinded to intervention
or control group.
Blinding of outcome assessment (detection
bias)
Self-reported fever
Low risk Participants who self reported fever were
blinded to intervention or control group.
Malaria cases were confirmed by blood
smear examination
Blinding of outcome assessment (detection
bias)
All other outcomes
Low risk No blinding of outcome assessors de-
scribed, however the review authors judge
that lack of blinding was very unlikely to
have impacted the measurement of preva-
lence through cross-sectional survey and
blood smear examination
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Insufficient information to judge risk of
attrition bias. 68% of the total popu-
lation took part in the postintervention
prevalence survey, but the number of par-
ticipants missing from each intervention
group is not described, and reason formiss-
ing data is not provided
Selective reporting (reporting bias) Low risk All expected outcomes reported.
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Magris 2007 (Continued)
Other bias Low risk Recruitment bias: low risk
Baseline imbalance: villages were paired by
baseline incidence
Loss of clusters: no loss of clusters
Incorrect analysis: adjusted
Comparability with RCTs randomizing in-
dividuals: suitable for comparison
Marbiah 1998
Methods Study design: cRCT
Unit of allocation: village (17 villages were paired according to size, altitude, climate,
and presence of a health centre; 1 village in each pair was then randomized to the
intervention; children were also randomized individually to either chemoprophylaxis
with pyrimethamine/dapsone or placebo. The review analysis focused on the placebo
group in order to exclude the effect of chemoprophylaxis)
Number of units: 9:9
Length of follow-up: 1 year
Outcome assessment: weekly active case detection where each child recruited into the
study was visited by a field worker, and if meeting specific criteria a blood smear was
examined. Anaemia was assessed through a cross-sectional survey conducted 9 months
postintervention
Adjustment: to account for clustering, theCIs for the protective efficacies were calculated
from the mean and standard error of the log rate ratios of each pair
Participants Number of participants: 920
Inclusion criteria: children aged 3 months to 6 years
Interventions Type of intervention: bed net (n = 470)
Insecticide and dosage: lambda-cyhalothrin (10 mg/m2)
Retreatment: not stated
Usage: not stated
Control: no net (n = 450)
Co-interventions: children were randomized individually to either chemoprophylaxis
with pyrimethamine/dapsone (Maloprim) or placebo.Only the placebo group is included
in this analysis
Outcomes Outcomes measured: incidence of malaria episodes (children aged 3 months to 6 years)
Notes Study location: 17 villages near the town of Bo, Sierra Leone
EIR: 35
Malaria transmission: hyperendemic
Main vectors: Anopheles gambiae
% P vivax cases: 0%
Risk of bias
Bias Authors’ judgement Support for judgement
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Random sequence generation (selection
bias)
Low risk Intervention group was randomly allocated
by a lottery.
Allocation concealment (selection bias) Low risk Low risk with the above randomization
process
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Not possible to blind participants and per-
sonnel, but the review authors judge that
this lack of blinding was unlikely to have
affected the outcome of malaria infection
Blinding of outcome assessment (detection
bias)
Self-reported fever
Unclear risk Children reporting fever during active
surveillance had parasitaemia confirmed by
blood smear
Blinding of outcome assessment (detection
bias)
All other outcomes
Low risk No other outcomes were assessed.
Incomplete outcome data (attrition bias)
All outcomes
Low risk No missing outcome data
Selective reporting (reporting bias) Low risk All expected outcomes reported.
Other bias Low risk Recruitment bias: low risk
Baseline imbalance: the pre-intervention
incidence rate was not provided, but in-
tervention groups were comparable for
pre-intervention mean haematocrit and
splenomegaly prevalence
Loss of clusters: none
Incorrect analysis: adjusted
Comparability with RCTs randomizing in-
dividuals: suitable for comparison
Moyou-Somo 1995
Methods Study design: cRCT
Unit of allocation: household (40 households with number of people varying from 5 to
25)
Number of units: 20:20
Length of follow-up: 12 months (January to December 1992)
Outcome assessment: cross-sectional surveys conducted every 2 months.
Adjustment: for quarter and age group
Participants Number of participants: approximately 480
Inclusion criteria: all inhabitants of the study area; children aged 15 and under
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Interventions Intervention: bed net (n = approximately 240)
Insecticide and dosage: deltamethrin; target dose 25 mg/m2
Retreatment: after 6 months
Usage: Not described
Control: no net (n = approximately 240)
Outcomes Parasite prevalence
Notes Study location: 2 villages in Kumba, South West Cameroon: Kossala (high prevalence)
and Mbonge Road (low prevalence)
EIR: 10 to 20
Malaria transmission: intense and perennial
Main vectors: Anopheles gambiae s.l.
% P vivax cases: 0%
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk It was stated that villages were paired
and randomly allocated, but randomiza-
tion programme is not described
Allocation concealment (selection bias) Unclear risk Allocation concealment not described.
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Not possible to blind participants and per-
sonnel, however the review authors judge
the risk of bias to be low for the outcome
of prevalence
Blinding of outcome assessment (detection
bias)
Self-reported fever
Low risk This outcome was not assessed.
Blinding of outcome assessment (detection
bias)
All other outcomes
Low risk Not described if blood film examiners were
blinded to the intervention group. The re-
view authors judge the risk of bias to be low
for the outcome of prevalence as the survey
was cross-sectional and the measurement is
objective
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Insufficient reporting of number random-
ized and number present at each survey to
permit judgement
Selective reporting (reporting bias) Low risk Outcomes reported are those that would
have been expected to have been reported
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Other bias Unclear risk Recruitment bias: low risk
Baseline imbalance: unclear risk; baseline
prevalence not reported
Loss of clusters: none
Incorrect analysis: no adjustment to CIs to
account for clustering
Comparability with RCTs randomizing in-
dividuals: not comparable unless clustering
is adjusted for by review authors
Nevill 1996
Methods Study design: cRCT
Unit of allocation: administrative zones. Stratified by north, southeast, and southwest
divisions of the study area due to significant differences in preliminary mortality and
hospital presentation data
Number of units: 28:28
Length of follow-up: 2 years
Outcome assessment: paediatric ward surveillance. Blood sample and clinical diagnosis
taken.
Biannual census; datawere supplementedwith 6-weekly house-to-house vital registration
of births and deaths
Participants Number of participants: 22,998
Inclusion criteria: children 1 to 59 months
Interventions Intervention: bed net (n = 11,566)
Insecticide and dosage: permethrin suspension (0.5 g/mL)
Retreatment: nets dipped again after 6 months
Usage: 77% in intervention group; < 1% in control
Control: no net (n = 11,432)
Outcomes Outcomes measured:
• Mortality rate
• P falciparum positive admissions
• Severe malaria admissions (defined as confirmed P falciparum parasitaemia
accompanied by:
◦ coma, defined as being unable to localize a painful stimulus (assessed after 1
hour following a seizure or administration of anticonvulsants and after correction of
hypoglycaemia);
◦ prostration, defined as being unable to breastfeed or sit unassisted;
◦ multiple seizures, 2 or more convulsions within 24 hours prior to admission;
◦ severe malaria anaemia, a haemoglobin of less than 5.1 g/dL, and an
associated parasitaemia greater than 10,000 parasites per microlitre of blood;
◦ hyperparasitaemia, more than 20% of red cells infected;
◦ death without any of the aforementioned complications but without
evidence of an alternative diagnosis.
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Notes Study location: Kilifi District, Kenya
EIR: 10 to 30
Malaria transmission: hyperendemic. Baseline parasite rate in children 1 to 9 years: 49%
in the peak season, with seasonal fluctuation
Main vectors: Anopheles gambiae s.l. complex
P vivaxmalaria: 0%
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Intervention allocation by public lottery
(information provided by CL)
Allocation concealment (selection bias) Low risk Low risk given the above intervention allo-
cation procedure
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Not possible to blind participants and per-
sonnel, but this was not likely to have in-
troduced bias
Blinding of outcome assessment (detection
bias)
Self-reported fever
Unclear risk Incidence was determined from hospital
admissions. This would involve self report-
ing of fever, though cases were confirmed
as positive for parasitaemia
Blinding of outcome assessment (detection
bias)
All other outcomes
Low risk Unclear if outcome assessors were blinded,
but this was not likely to have introduced
bias for mortality or severe malaria mea-
surement
Incomplete outcome data (attrition bias)
All outcomes
Low risk Number randomized is based on full popu-
lation census. The paper provides sufficient
confidence that all deaths and hospital at-
tendances are recorded
Selective reporting (reporting bias) Low risk All stated outcomes reported.
Other bias Low risk Recruitment bias: low risk
Baseline imbalance: the pre-intervention
differences are controlled for in the ad-
justed risk ratios
Loss of clusters: none
Incorrect analysis: adjusted
Comparability with RCTs randomizing in-
dividuals: suitable for comparison
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Phillips-Howard 2003
Methods Study design: cRCT
Unit of allocation: village (allocation of 221 villages by open lottery; 79 clusters in
Asembo, population 55,000; 142 clusters in Gem, population 70,000)
Number of units: 113:108
Length of follow-up: 2 years (Asembo: Jan 1997 to Dec 1998; Gem: Jan 1998 to Dec
1999)
Outcome assessment: mortality was monitored by a full demographic system with bian-
nual census. Morbidity was monitored with three cross-sectional surveys completed at
baseline (Nov 1996), midpoint (Feb to Mar 1998), and the end of the morbidity study
(1998).
Adjustment: analysis for mortality rates was completed at the village level and so did not
need to take clustering into account. Morbidity analysis controlled for clustering with
an exchangeable correlation structure assumed for residents within a village
Participants Number of participants: approximately 18,500
Inclusion criteria: children aged 1 to 59 months who had lived in the study area for at
least 1 month
Interventions Intervention: treated bed nets
Insecticide and dosage: permethrin (500 mg/m2)
Retreatment: aimed to retreat bed nets every 6 months. Due to terrorist bombing of the
US embassy, retreatment in some villages was delayed in 1998 and 1999.
Usage: 66% adherence
Control: no net
Outcomes Outcomes measured:
• All-cause mortality (Asembo and Gem)
• Prevalence of people that have clinical malaria (Asembo only)
Notes Study location: Asembo and Gem, in Nyanza Province on the shore of Lake Victoria,
Kenya
EIR: 60 to 300
Malaria endemicity: holoendemic
Main vector: Anopheles gambiae and Anopheles funestus
P vivax malaria: 0%
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Villages were randomly assigned by public
lottery.
Allocation concealment (selection bias) Low risk Village representatives chose a sealed enve-
lope detailing their intervention group
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Not possible to blind participants and per-
sonnel, however the review authors judge
this was unlikely to have introduced bias
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Phillips-Howard 2003 (Continued)
to the outcomes of mortality or clinical
episodes of malaria
Blinding of outcome assessment (detection
bias)
Self-reported fever
Low risk This outcome was not assessed.
Blinding of outcome assessment (detection
bias)
All other outcomes
Low risk Outcome assessors were not blinded to in-
tervention status of participants, but the
review authors judge this was unlikely to
have introduced bias to the measurement
of mortality or prevalence through cross-
sectional surveys
Incomplete outcome data (attrition bias)
All outcomes
High risk 19 of 79 villages in Asembo region ex-
cluded from the cross-sectional studieswere
in the southernmost area of Asembo, be-
cause longitudinal surveillance was still on-
going. The reason was unrelated to the in-
tervention group. The study included chil-
dren aged 1 to 59 months, but only chil-
dren aged 1 to 3 years were sampled for the
morbidity analysis
Selective reporting (reporting bias) Low risk Outcomes reported are those detailed in the
study protocol.
Other bias Low risk Recruitment bias: low risk
Baseline imbalance: no significant variation
in incidence rate or parasitaemia at baseline
Loss of clusters: none
Incorrect analysis: adjusted
Comparability with RCTs randomizing in-
dividuals: suitable for comparison
Rabarison 1995
Methods Study design: cRCT
Unit of allocation: households
Number of units: 91 households at baseline (46 intervention households, 45 controls).
78 households at the end of the study (39 intervention households, 39 controls)
Length of follow-up (study dates): 2 distinct periods for a total of 13 months (February
1993 to July 1993, and October 1993 to June 1994)
Outcome assessment: passive surveillance through medical consultations at Ankazobé
(Institut Pasteur)
Participants Number of participants: 501 at baseline (244 in the intervention group, 257 in the
control group). 431 at the end of the study (208 in the intervention group, 223 in the
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Rabarison 1995 (Continued)
control group)
Inclusion criteria: households in Ankazobé district II
Interventions Intervention: curtain nets attached to the doors and windows of bedrooms
Insecticide and dosage: deltamethrin (25 mg/m2)
Net retreatment: done 3 times (specific dates not provided)
Usage: not described. Likely to be high as nets are fitted by study personnel and then left
Control: untreated nets attached to the doors and windows of bedrooms
Outcomes Outcomes measured: number of clinical episodes (defined as axillary body temperature
over 37.5 C° plus parasitaemia > 1500/ µL)
Notes Study location: Ankazobé (Madagascar), at altitude of 1300 m
EIR: < 10
Malaria transmission (perennial, seasonal, etc.): low seasonal transmission. “Stability
index” described as <= 2.5
Main vector species: Anopheles funestus and Anopheles gambiae
% P vivax cases: 0%
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Houses were drawn by lottery.
Allocation concealment (selection bias) Low risk Low risk of bias considering the above al-
location procedure
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Single-blind: participants were blinded to
the impregnation status of installed cur-
tains
Blinding of outcome assessment (detection
bias)
Self-reported fever
Low risk Passive case detection would have de-
pended on self reporting, but as partici-
pants were blinded to intervention this was
unlikely to have introduced detection bias.
Caseswere registered only if confirmedpos-
itive for parasitaemia
Blinding of outcome assessment (detection
bias)
All other outcomes
Low risk Other outcomes were not assessed.
Incomplete outcome data (attrition bias)
All outcomes
Low risk Loss of households was explained as being
mainly due to participants relocating fol-
lowing cyclones in February 1994. Loss was
balanced between groups
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Rabarison 1995 (Continued)
Selective reporting (reporting bias) Low risk Expected outcomes are reported, except for
data for August 1993 to September 1993,
which is likely due to limited cases outside
of the rain season
Other bias Unclear risk Recruitment bias: low risk
Baseline imbalance: unclear risk. Baseline
prevalence not reported
Loss of clusters: 13 clusters lost due to
participants relocating following cyclones.
These were balanced in numbers between
groups
Incorrect analysis: no adjustment to CIs to
account for clustering
Comparability with RCTs randomizing in-
dividuals: not comparable unless clustering
is adjusted for by review authors
Rowland 1996
Methods Study design: individual RCT
Unit of allocation: household (random allocation of 192 households after a first random
selection of 20% of all households from a census list; the aim of this procedure was to
measure the impact of treated nets in a condition of low net usage)
Number of units: 97:95
Length of follow-up: 6 months
Outcome assessment: prevalence survey using health centre microscopists before study
(followed by treatment) and after 6 months. Passive case detection through health centre
attendance data
Participants Number of participants: 2792
Inclusion criteria: chosen from 2 Afghan refugee camps. All ages
Interventions Type of intervention: bed net (n = 1398)
Insecticide and dosage: permethrin (0.5 g/m2)
Retreatment: not stated
Usage: 66% 7 nights per week, 82% 3 to 6 nights per week
Control: no net (n = 1394)
Outcomes Outcomes measured:
• Incidence of malaria episodes (both P falciparum and P vivax)
• Prevalence of any parasitaemia (both P falciparum and P vivax)
Notes Study location: Mardan District, North West Frontier Province, North West Pakistan
EIR: low
Malaria transmission: unstable; 22% of individuals reported having had malaria in the
past year
Main vectors: Anopheles culicifacies and Anopheles stephensi
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Rowland 1996 (Continued)
% P vivax cases: 77% of all cases
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Trial families were randomly selected from
the total population and then randomly di-
vided into intervention and control groups,
but randomization process is not described
Allocation concealment (selection bias) Unclear risk Not described
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Blinding was not possible, but the review
authors judge that this was unlikely to have
impacted the outcome of malaria infection
Blinding of outcome assessment (detection
bias)
Self-reported fever
Unclear risk The review authors judge that partici-
pant knowledge of their intervention group
could have influenced the self reporting of
fever
Blinding of outcome assessment (detection
bias)
All other outcomes
Low risk No blinding of outcome assessors de-
scribed, however the review authors judge
that a lack of blinding was very unlikely to
have impacted the measurement of preva-
lence through objective tests
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk No reason for missing outcome data pro-
vided.
Selective reporting (reporting bias) Low risk All expected outcomes reported.
Other bias Low risk Recruitment bias: low risk
Baseline imbalance: the pre-intervention
prevalence of P falciparum and P vivax was
comparable between the intervention and
control group.
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Sexton 1990
Methods Study design: cRCT
Unit of allocation: household
Number of units: 35 treated bed nets: 35 treated curtains: 35 control
Length of follow-up: 15 weeks
Outcome assessment: all participants given curative treatment at enrolment. New P
falciparum infections were determined by weekly blood smears from all family members.
Only infections occurring > 4 weeks after a treatment were considered new infections
Participants Number of participants: 481
Inclusion criteria: all ages
Interventions Intervention: bed nets (n = 166) and curtains (n = 156)
Insecticide and dosage: permethrin (0.5 g/m2)
Retreatment: not stated
Usage: 70% to 73%
Control: no net (n = 159)
Outcomes Outcomes measured: incidence of parasitaemia
Notes Study location: Uriri, western Kenya
EIR: not stated
Malaria transmission: holoendemic. 77% parasitaemia
Main vectors: Anopheles gambiae s.l.
The trial compared treated bed nets, treated curtains, and no nets. As both interventions
met the criteria for the review, in the analysis we added the number in the treated bed
net group to the number in the treated curtain group to give the total number of cases
and weeks at risk in a combined intervention group
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Stated randomized, but randomization
procedure not described
Allocation concealment (selection bias) Unclear risk Not described
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Not possible to blind participants and per-
sonnel, but this was not likely to have intro-
duced bias to the outcome of parasitaemia
Blinding of outcome assessment (detection
bias)
Self-reported fever
Low risk The outcome was not reported.
Blinding of outcome assessment (detection
bias)
All other outcomes
Low risk Outcome assessors were not blinded to in-
tervention status of participants, but the
review authors judge this was unlikely to
have introduced bias to the measurement
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Sexton 1990 (Continued)
of parasitaemia as all family members had
a blood smear taken and the measurement
is objective
Incomplete outcome data (attrition bias)
All outcomes
Low risk No reason given formissing data, but num-
bers lost were < 5% (5 individuals lost from
bednet group, 1 fromcurtain group, 0 from
control group)
Selective reporting (reporting bias) Low risk All expected outcomes reported.
Other bias Unclear risk Recruitment bias: low risk
Baseline imbalance: unclear. All partici-
pants received treatment at enrolment, but
the baseline prevalence or incidence is not
provided
Loss of clusters: none
Incorrect analysis: no adjustment to CIs to
account for clustering
Comparability with RCTs randomizing in-
dividuals: not comparable unless clustering
is adjusted for by review authors
Smithuis 2013
Methods Study design: cRCT
Unit of allocation: village (paired on the basis of geographical location)
Number of units: 10:10
Length of follow-up: 1 year
Outcome assessment: passive case detection at local health centre.Childrenwere followed
up in 2 postintervention cross-sectional surveys: after 5 months and at the end of the
study (10 months).
Adjustment: cluster adjustment using intraclass correlation coefficient of 0.048, between-
cluster variation 0.006, and within-cluster variation 0.12
Participants Number of participants: 8395
Inclusion criteria: children under 10 years of age
Interventions Intervention: bed net (n = 4066)
Insecticide and dosage: deltamethrin (25 mg/m2)
Retreatment: not stated
Usage: not stated
Control: no net (n = 4109)
Outcomes Outcomes measured:
• Malaria prevalence
• Malaria incidence
• Number of deaths
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Smithuis 2013 (Continued)
• Number of cases of severe malaria
Notes Study location: Rakhine State, Western Myanmar, in 2 areas: Dabhine and Myothugyi
EIR: not stated
Malaria transmission: predominantly low with pockets of intense transmission
Main vectors: not stated
% P vivax cases: 52%, and 2% P falciparum/P vivax mixed
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk 1 village was selected from each pair using
a computer-generated random number to
receive ITNs
Allocation concealment (selection bias) Low risk Low risk of bias considering the above al-
location procedure
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Impossible to blind implementers or inhab-
itants to intervention, but this was unlikely
to have introduced bias to the outcomes of
malaria infection, morbidity, or mortality
Blinding of outcome assessment (detection
bias)
Self-reported fever
Unclear risk Incidence was monitored through passive
case detection and depended on self report-
ing of a fever; cases were confirmed by mi-
croscopy
Blinding of outcome assessment (detection
bias)
All other outcomes
Low risk The outcomes of mortality, severe malaria
cases, and parasite prevalence measured
through cross-sectional surveys were un-
likely to have been influenced by knowl-
edge of intervention allocation
Incomplete outcome data (attrition bias)
All outcomes
Low risk Missing data were balanced across the in-
tervention groups and numbers lost were
below 5%; 4.5% of the experimental group
and 2.9% of the control group had moved
away or were absent for the final follow-
up survey. All other participants were ac-
counted for
Selective reporting (reporting bias) Low risk All expected outcomes reported.
Other bias Low risk Recruitment bias: low risk
Baseline imbalance: the pre-intervention
prevalence rates were adjusted for
Loss of clusters: 2 planned clusters were
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Smithuis 2013 (Continued)
lost, but this was before randomization
Incorrect analysis: adjusted
Comparability with RCTs randomizing in-
dividuals: suitable for comparison
Snow 1987
Methods Study design: cRCT
Unit of allocation: household (allocation of 110 compounds was done randomly after
stratification by 3 levels of “spleen rate”: no child with enlarged spleen in household, 1
child, more than 1 child)
Number of units: 60:50
Length of follow-up: 6 months (May to November 1987)
Outcome assessment: weekly morbidity survey of participants with those reporting a
fever having a blood examination, and 2 cross-sectional surveys: 1 before intervention
in May 1987 and 1 after 6 months in November, following the peak of the transmission
season
Participants Number of participants: 389
Inclusion criteria: children aged 1 to 9
Interventions Intervention: bed net (n = 205)
Insecticide and dosage: permethrin (500 mg/m2)
Retreatment: not described
Usage: not described
Control: placebo-treated net (n = 184). The proportion of households in the village that
possessed nets at baseline was about 98%
Outcomes Outcomes measured:
• Incidence of new episodes of malaria
• Prevalence of any parasitaemia
• Number of deaths
Notes Study location: Katchang, North bank of River Gambia
EIR: 10
Malaria transmission: hyperendemic
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Randomization stated, but process not de-
scribed.
Allocation concealment (selection bias) Unclear risk Allocation concealment process not de-
scribed.
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Snow 1987 (Continued)
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Participants blinded to treated or untreated
net.
Blinding of outcome assessment (detection
bias)
Self-reported fever
Low risk Outcome assessors blinded to treated or
untreated net.
Blinding of outcome assessment (detection
bias)
All other outcomes
Low risk Outcome assessors blinded to treated or
untreated net.
Incomplete outcome data (attrition bias)
All outcomes
Low risk Losses of participants were explained and
equal between groups
Selective reporting (reporting bias) Low risk All expected outcomes reported.
Other bias Low risk Recruitment bias: low risk
Baseline imbalance: low, as intervention
groups were stratified by prevalence
Loss of clusters: none
Incorrect analysis: no adjustment to CIs to
account for clustering
Comparability with RCTs randomizing in-
dividuals: not comparable unless clustering
is adjusted for by review authors
Sochantha 2006
Methods Study design: cRCT
Unit of allocation: villages (paired on the basis of baseline prevalence)
Number of units: 17:17
Length of follow-up: 10 months
Outcome assessment: passive surveillance systemwith villagemalaria workers using rapid
diagnostic tests (as a proxy measure to estimate malaria incidence), and blood smear
cross-sectional survey after 10 months for prevalence assessment
Adjustment: used an exchangeable correlation matrix to adjust for clustering
Participants Number of participants: 10,726
Inclusion criteria: people of all ages
Interventions Intervention: bed net (n = 6106)
Insecticide and dosage: deltamethrin (25 mg/m2)
Retreatment: at end of follow-up period
Usage: 87% intervention group
Control: no net (n = 4620). 14% of control group reported use of an ITN
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Outcomes Outcomes measured:
• P falciparum prevalence
• P falciparum positive consultation rate (per person per year)
Notes Study location: Rattanakiri, North East Cambodia
EIR: 6.0
Malaria transmission: perennial, with a peak during the rainy season
Main vectors: Anopheles dirus
% P vivax cases: not reported
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computerized random number generation
Allocation concealment (selection bias) Unclear risk Not described
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Not possible to blind participants and per-
sonnel, but this was not likely to have in-
troduced performance bias
Blinding of outcome assessment (detection
bias)
Self-reported fever
Unclear risk It is unclear if the passive surveillance sys-
tem was blinded to intervention status of
participants. An objective rapid diagnostic
test was used for assessment, but as this was
only on participants self reporting a fever,
there is the possibility of bias
Blinding of outcome assessment (detection
bias)
All other outcomes
Low risk Intervention group was not identified to
blood smear examiners for the cross-sec-
tional survey
Incomplete outcome data (attrition bias)
All outcomes
Low risk The intended sample size for the cross-sec-
tional survey is unclear (250 per village, or
80% of population in villages with < 250,
though the size of individual villages is not
described). However, the number sampled
is balanced across intervention groups
Selective reporting (reporting bias) Low risk All expected outcomes reported.
Other bias Low risk Recruitment bias: low risk
Baseline imbalance: the pre-intervention
prevalence rates were adjusted for
Loss of clusters: 2 planned clusters were
lost, but this was before randomization
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Sochantha 2006 (Continued)
Incorrect analysis: adjusted
Comparability with RCTs randomizing in-
dividuals: unclear
Abbreviations: cRCT: cluster-randomized controlled trial; CI: confidence interval; EIR: entomological inoculation rate; ITN: insecti-
cide-treated net; RCT: randomized controlled trial.
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Bhatt 2012 The study design is not appropriate as it grouped villages into just three clusters. A single cluster was
randomised to each of the ITN, UTN or NN arms
Sahu 2008 The study design is not appropriate as it grouped villages into just three clusters. A single cluster was
randomised to each of the ITN, UTN or NN arms
Sharma 2009 The study design is not appropriate as it grouped villages into just three clusters. A single cluster was
randomised to each of the ITN, UTN or NN arms
Snow 1988 Comparison was between untreated nets and no nets. No participants received an ITN
Soleimani-Ahmadi 2012 The study design is not appropriate as it grouped villages into just two clusters. A single cluster was
randomised to each of the ITN and UTN arms
Thang 2009 The control group is not appropriate. The study assessed the impact of introducing insecticide treated
hammocks to forest workers, compared to those not receiving hammocks. However, the participants all
lived in villages with a high coverage of ITNs (88.17% in the control arm), and therefore were unsuitable
to act as a control
Zaim 1998 Definition of measured outcome described as “incidence of malaria” is unclear. No other epidemiological
outcomes were reported
Abbreviations: ITN: insecticide-treated net; NN: no net; UTN: untreated net.
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D A T A A N D A N A L Y S E S
Comparison 1. Insecticide-treated nets versus no nets
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Child mortality from all causes 5 0 Rate Ratio (Random, 95% CI) 0.83 [0.77, 0.89]
2 P falciparum uncomplicated
episodes
5 0 Rate Ratio (Random, 95% CI) 0.55 [0.48, 0.64]
3 P falciparum uncomplicated
episodes (cumulative incidence)
2 0 Risk Ratio (Random, 95% CI) 0.44 [0.31, 0.62]
4 P vivax uncomplicated episodes
(cumulative incidence)
2 0 Risk Ratio (Random, 95% CI) 0.61 [0.48, 0.77]
5 Any Plasmodium spp.
uncomplicated episodes
1 0 Rate Ratio (Fixed, 95% CI) 0.50 [0.28, 0.90]
6 P falciparum prevalence 6 0 Risk Ratio (Random, 95% CI) 0.83 [0.71, 0.98]
7 P vivax prevalence 2 0 Risk Ratio (Random, 95% CI) 1.00 [0.75, 1.34]
8 Severe malaria episodes 2 8175 Rate Ratio (Random, 95% CI) 0.56 [0.38, 0.82]
9 Anaemia (mean packed cell
volume)
5 9182 Mean Difference (Random, 95% CI) 1.29 [0.42, 2.16]
Comparison 2. Insecticide-treated nets versus untreated nets
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Child mortality from all causes 2 Rate Ratio (Random, 95% CI) 0.67 [0.36, 1.23]
2 P falciparum uncomplicated
episodes
5 Rate Ratio (Random, 95% CI) 0.58 [0.44, 0.78]
3 P vivax uncomplicated episodes 3 Rate Ratio (Random, 95% CI) 0.73 [0.51, 1.05]
4 P vivax uncomplicated episodes
(cumulative incidence)
3 Risk Ratio (Random, 95% CI) 0.59 [0.30, 1.18]
5 Any Plasmodium spp.
uncomplicated episodes
(cumulative incidence)
2 Risk Ratio (Random, 95% CI) 0.47 [0.17, 1.28]
6 P falciparum prevalence 3 Risk Ratio (Random, 95% CI) 0.91 [0.78, 1.05]
7 P vivax prevalence 1 Risk Ratio (Fixed, 95% CI) 0.68 [0.25, 1.85]
8 Any Plasmodium spp. prevalence 1 Risk Ratio (Fixed, 95% CI) 0.17 [0.05, 0.53]
9 Anaemia (mean packed cell
volume)
2 Mean Difference (Random, 95% CI) 0.48 [-0.54, 1.50]
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Analysis 1.1. Comparison 1 Insecticide-treated nets versus no nets, Outcome 1 Child mortality from all
causes.
Review: Insecticide-treated nets for preventing malaria
Comparison: 1 Insecticide-treated nets versus no nets
Outcome: 1 Child mortality from all causes
Study or subgroup Favours ITN NN log [Rate Ratio] Rate Ratio Weight Rate Ratio
N N (SE) IV,Random,95% CI IV,Random,95% CI
Nevill 1996 0 0 -0.3567 (0.1419) 6.4 % 0.70 [ 0.53, 0.92 ]
Binka 1996 0 0 -0.1863 (0.0943) 14.6 % 0.83 [ 0.69, 1.00 ]
Phillips-Howard 2003 0 0 -0.1744 (0.0444) 65.7 % 0.84 [ 0.77, 0.92 ]
Halbluetzel 1996 0 0 -0.1625 (0.0991) 13.2 % 0.85 [ 0.70, 1.03 ]
Smithuis 2013 0 0 0.2729 (1.3625) 0.1 % 1.31 [ 0.09, 18.98 ]
Total (95% CI) 0 0 100.0 % 0.83 [ 0.77, 0.89 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 1.69, df = 4 (P = 0.79); I2 =0.0%
Test for overall effect: Z = 5.17 (P < 0.00001)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
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Analysis 1.2. Comparison 1 Insecticide-treated nets versus no nets, Outcome 2 P falciparum
uncomplicated episodes.
Review: Insecticide-treated nets for preventing malaria
Comparison: 1 Insecticide-treated nets versus no nets
Outcome: 2 P falciparum uncomplicated episodes
Study or subgroup Experimental Control log [Rate Ratio] Rate Ratio Weight Rate Ratio
N N (SE) IV,Random,95% CI IV,Random,95% CI
Henry 2005 (1) 0 0 -0.844 (0.2767) 7.6 % 0.43 [ 0.25, 0.74 ]
Marbiah 1998 0 0 -0.6757 (0.1302) 34.5 % 0.51 [ 0.39, 0.66 ]
Nevill 1996 0 0 -0.5447 (0.1527) 25.1 % 0.58 [ 0.43, 0.78 ]
Sexton 1990 0 0 -0.5703 (0.1697) 20.3 % 0.57 [ 0.41, 0.79 ]
Sochantha 2006 (2) 0 0 -0.3285 (0.2176) 12.4 % 0.72 [ 0.47, 1.10 ]
Total (95% CI) 0 0 100.0 % 0.55 [ 0.48, 0.64 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 2.82, df = 4 (P = 0.59); I2 =0.0%
Test for overall effect: Z = 7.73 (P < 0.00001)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours ITN Favours NN
(1) !” Henry 2005 study’s primary vector species (An. gambiae ss) was strongly resistant to pyrethroids; kdr allelic frequency of ˜90%
(2) Sochantha 2006 study was conducted in a high transmission setting in Cambodia (EIR = 6.0)
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Analysis 1.3. Comparison 1 Insecticide-treated nets versus no nets, Outcome 3 P falciparum
uncomplicated episodes (cumulative incidence).
Review: Insecticide-treated nets for preventing malaria
Comparison: 1 Insecticide-treated nets versus no nets
Outcome: 3 P falciparum uncomplicated episodes (cumulative incidence)
Study or subgroup ITN NN log [Risk Ratio] Risk Ratio Weight Risk Ratio
N N (SE) IV,Random,95% CI IV,Random,95% CI
Rowland 1996 0 0 -0.9577 (0.2018) 66.1 % 0.38 [ 0.26, 0.57 ]
Smithuis 2013 0 0 -0.5841 (0.2927) 33.9 % 0.56 [ 0.31, 0.99 ]
Total (95% CI) 0 0 100.0 % 0.44 [ 0.31, 0.62 ]
Heterogeneity: Tau2 = 0.01; Chi2 = 1.10, df = 1 (P = 0.29); I2 =9%
Test for overall effect: Z = 4.70 (P < 0.00001)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours ITN Favours NN
Analysis 1.4. Comparison 1 Insecticide-treated nets versus no nets, Outcome 4 P vivax uncomplicated
episodes (cumulative incidence).
Review: Insecticide-treated nets for preventing malaria
Comparison: 1 Insecticide-treated nets versus no nets
Outcome: 4 P vivax uncomplicated episodes (cumulative incidence)
Study or subgroup ITN NN log [Risk Ratio] Risk Ratio Weight Risk Ratio
N N (SE) IV,Random,95% CI IV,Random,95% CI
Rowland 1996 0 0 -0.5443 (0.1094) 84.3 % 0.58 [ 0.47, 0.72 ]
Smithuis 2013 0 0 -0.2201 (0.29) 15.7 % 0.80 [ 0.45, 1.42 ]
Total (95% CI) 0 0 100.0 % 0.61 [ 0.48, 0.77 ]
Heterogeneity: Tau2 = 0.00; Chi2 = 1.09, df = 1 (P = 0.30); I2 =9%
Test for overall effect: Z = 4.19 (P = 0.000028)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours ITN Favours NN
67Insecticide-treated nets for preventing malaria (Review)
Copyright © 2018 The Authors. Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The
Cochrane Collaboration.
Analysis 1.5. Comparison 1 Insecticide-treated nets versus no nets, Outcome 5 Any Plasmodium spp.
uncomplicated episodes.
Review: Insecticide-treated nets for preventing malaria
Comparison: 1 Insecticide-treated nets versus no nets
Outcome: 5 Any Plasmodium spp. uncomplicated episodes
Study or subgroup ITN NN log [Rate Ratio] Rate Ratio Weight Rate Ratio
N N (SE) IV,Fixed,95% CI IV,Fixed,95% CI
Smithuis 2013 0 0 -0.6892 (0.2995) 100.0 % 0.50 [ 0.28, 0.90 ]
Total (95% CI) 0 0 100.0 % 0.50 [ 0.28, 0.90 ]
Heterogeneity: not applicable
Test for overall effect: Z = 2.30 (P = 0.021)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
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Analysis 1.6. Comparison 1 Insecticide-treated nets versus no nets, Outcome 6 P falciparum prevalence.
Review: Insecticide-treated nets for preventing malaria
Comparison: 1 Insecticide-treated nets versus no nets
Outcome: 6 P falciparum prevalence
Study or subgroup ITN NN log [Risk Ratio] Risk Ratio Weight Risk Ratio
N N (SE) IV,Random,95% CI IV,Random,95% CI
Rowland 1996 0 0 -0.5526 (0.2592) 10.0 % 0.58 [ 0.35, 0.96 ]
Moyou-Somo 1995 0 0 -0.348 (0.305) 7.2 % 0.71 [ 0.39, 1.28 ]
Smithuis 2013 0 0 -0.3066 (0.4627) 3.1 % 0.74 [ 0.30, 1.82 ]
Fraser-Hurt 1999 0 0 -0.2963 (0.1637) 25.0 % 0.74 [ 0.54, 1.02 ]
Sochantha 2006 (1) 0 0 -0.0943 (0.1717) 22.8 % 0.91 [ 0.65, 1.27 ]
Phillips-Howard 2003 0 0 0 (0.1451) 31.9 % 1.00 [ 0.75, 1.33 ]
Total (95% CI) 0 0 100.0 % 0.83 [ 0.71, 0.98 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 4.73, df = 5 (P = 0.45); I2 =0.0%
Test for overall effect: Z = 2.27 (P = 0.024)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours ITN Favours NN
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(1) Sochantha 2006 study was conducted in a high transmission setting in Cambodia (EIR = 6.0)
Analysis 1.7. Comparison 1 Insecticide-treated nets versus no nets, Outcome 7 P vivax prevalence.
Review: Insecticide-treated nets for preventing malaria
Comparison: 1 Insecticide-treated nets versus no nets
Outcome: 7 P vivax prevalence
Study or subgroup ITN NN log [Risk Ratio] Risk Ratio Weight Risk Ratio
N N (SE) IV,Random,95% CI IV,Random,95% CI
Rowland 1996 0 0 0.0916 (0.1777) 70.1 % 1.10 [ 0.77, 1.55 ]
Smithuis 2013 0 0 -0.2066 (0.2719) 29.9 % 0.81 [ 0.48, 1.39 ]
Total (95% CI) 0 0 100.0 % 1.00 [ 0.75, 1.34 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.84, df = 1 (P = 0.36); I2 =0.0%
Test for overall effect: Z = 0.02 (P = 0.99)
Test for subgroup differences: Not applicable
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Analysis 1.8. Comparison 1 Insecticide-treated nets versus no nets, Outcome 8 Severe malaria episodes.
Review: Insecticide-treated nets for preventing malaria
Comparison: 1 Insecticide-treated nets versus no nets
Outcome: 8 Severe malaria episodes
Study or subgroup ITN NN log [Rate Ratio] Rate Ratio Weight Rate Ratio
N N (SE) IV,Random,95% CI IV,Random,95% CI
Nevill 1996 0 0 -0.5798 (0.1978) 99.7 % 0.56 [ 0.38, 0.83 ]
Smithuis 2013 4066 4109 -1.0881 (3.7492) 0.3 % 0.34 [ 0.00, 523.32 ]
Total (95% CI) 4066 4109 100.0 % 0.56 [ 0.38, 0.82 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.02, df = 1 (P = 0.89); I2 =0.0%
Test for overall effect: Z = 2.94 (P = 0.0033)
Test for subgroup differences: Not applicable
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Analysis 1.9. Comparison 1 Insecticide-treated nets versus no nets, Outcome 9 Anaemia (mean packed cell
volume).
Review: Insecticide-treated nets for preventing malaria
Comparison: 1 Insecticide-treated nets versus no nets
Outcome: 9 Anaemia (mean packed cell volume)
Study or subgroup Experimental Control Mean Difference (SE)
Mean
Difference Weight
Mean
Difference
N N IV,Random,95% CI IV,Random,95% CI
Fraser-Hurt 1999 60 60 1.5 (0.352) 30.0 % 1.50 [ 0.81, 2.19 ]
Henry 2005 83 72 2 (1.4102) 7.8 % 2.00 [ -0.76, 4.76 ]
Marbiah 1998 470 450 5.4 (2.3504) 3.3 % 5.40 [ 0.79, 10.01 ]
Phillips-Howard 2003 0 0 1.5 (0.4592) 26.5 % 1.50 [ 0.60, 2.40 ]
Smithuis 2013 3953 4034 0.33 (0.2776) 32.3 % 0.33 [ -0.21, 0.87 ]
Total (95% CI) 4566 4616 100.0 % 1.29 [ 0.42, 2.16 ]
Heterogeneity: Tau2 = 0.54; Chi2 = 13.00, df = 4 (P = 0.01); I2 =69%
Test for overall effect: Z = 2.89 (P = 0.0038)
Test for subgroup differences: Not applicable
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Analysis 2.1. Comparison 2 Insecticide-treated nets versus untreated nets, Outcome 1 Child mortality
from all causes.
Review: Insecticide-treated nets for preventing malaria
Comparison: 2 Insecticide-treated nets versus untreated nets
Outcome: 1 Child mortality from all causes
Study or subgroup log [Rate Ratio] Rate Ratio Weight Rate Ratio
(SE) IV,Random,95% CI IV,Random,95% CI
D’Alessandro 1995 -0.2877 (0.14) 88.4 % 0.75 [ 0.57, 0.99 ]
Snow 1987 -1.2612 (0.8644) 11.6 % 0.28 [ 0.05, 1.54 ]
Total (95% CI) 100.0 % 0.67 [ 0.36, 1.23 ]
Heterogeneity: Tau2 = 0.09; Chi2 = 1.24, df = 1 (P = 0.27); I2 =19%
Test for overall effect: Z = 1.28 (P = 0.20)
Test for subgroup differences: Not applicable
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Analysis 2.2. Comparison 2 Insecticide-treated nets versus untreated nets, Outcome 2 P falciparum
uncomplicated episodes.
Review: Insecticide-treated nets for preventing malaria
Comparison: 2 Insecticide-treated nets versus untreated nets
Outcome: 2 P falciparum uncomplicated episodes
Study or subgroup log [Rate Ratio] Rate Ratio Weight Rate Ratio
(SE) IV,Random,95% CI IV,Random,95% CI
Kamol-Ratanakul 1992 -0.6249 (0.3025) 13.5 % 0.54 [ 0.30, 0.97 ]
Luxemburger 1994 -0.5401 (0.2187) 18.4 % 0.58 [ 0.38, 0.89 ]
Magris 2007 -0.7765 (0.0713) 28.6 % 0.46 [ 0.40, 0.53 ]
Rabarison 1995 -0.2143 (0.1232) 25.3 % 0.81 [ 0.63, 1.03 ]
Snow 1987 -0.5534 (0.2859) 14.3 % 0.57 [ 0.33, 1.01 ]
Total (95% CI) 100.0 % 0.58 [ 0.44, 0.78 ]
Heterogeneity: Tau2 = 0.07; Chi2 = 15.84, df = 4 (P = 0.003); I2 =75%
Test for overall effect: Z = 3.63 (P = 0.00029)
Test for subgroup differences: Not applicable
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Analysis 2.3. Comparison 2 Insecticide-treated nets versus untreated nets, Outcome 3 P vivax
uncomplicated episodes.
Review: Insecticide-treated nets for preventing malaria
Comparison: 2 Insecticide-treated nets versus untreated nets
Outcome: 3 P vivax uncomplicated episodes
Study or subgroup log [Rate Ratio] Rate Ratio Weight Rate Ratio
(SE) IV,Random,95% CI IV,Random,95% CI
Kamol-Ratanakul 1992 -0.4106 (0.384) 22.5 % 0.66 [ 0.31, 1.41 ]
Luxemburger 1994 -0.2449 (0.2254) 65.3 % 0.78 [ 0.50, 1.22 ]
Magris 2007 -0.478 (0.5206) 12.2 % 0.62 [ 0.22, 1.72 ]
Total (95% CI) 100.0 % 0.73 [ 0.51, 1.05 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.26, df = 2 (P = 0.88); I2 =0.0%
Test for overall effect: Z = 1.71 (P = 0.088)
Test for subgroup differences: Not applicable
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Analysis 2.4. Comparison 2 Insecticide-treated nets versus untreated nets, Outcome 4 P vivax
uncomplicated episodes (cumulative incidence).
Review: Insecticide-treated nets for preventing malaria
Comparison: 2 Insecticide-treated nets versus untreated nets
Outcome: 4 P vivax uncomplicated episodes (cumulative incidence)
Study or subgroup log [Risk Ratio] Risk Ratio Weight Risk Ratio
(SE) IV,Random,95% CI IV,Random,95% CI
Kroeger 1995 (Peru Amazon) -0.4005 (0.3613) 29.0 % 0.67 [ 0.33, 1.36 ]
Kroeger 1995 (Peru Coast) -0.078 (0.1874) 37.3 % 0.92 [ 0.64, 1.34 ]
Kroeger 1999 -1.1394 (0.266) 33.7 % 0.32 [ 0.19, 0.54 ]
Total (95% CI) 100.0 % 0.59 [ 0.30, 1.18 ]
Heterogeneity: Tau2 = 0.30; Chi2 = 10.65, df = 2 (P = 0.005); I2 =81%
Test for overall effect: Z = 1.50 (P = 0.13)
Test for subgroup differences: Not applicable
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Analysis 2.5. Comparison 2 Insecticide-treated nets versus untreated nets, Outcome 5 Any Plasmodium
spp. uncomplicated episodes (cumulative incidence).
Review: Insecticide-treated nets for preventing malaria
Comparison: 2 Insecticide-treated nets versus untreated nets
Outcome: 5 Any Plasmodium spp. uncomplicated episodes (cumulative incidence)
Study or subgroup log [Risk Ratio] Risk Ratio Weight Risk Ratio
(SE) IV,Random,95% CI IV,Random,95% CI
Kroeger 1995 (Colombia) -1.2319 (0.5567) 52.6 % 0.29 [ 0.10, 0.87 ]
Kroeger 1995 (Ecuador) -0.2167 (0.6027) 47.4 % 0.81 [ 0.25, 2.62 ]
Total (95% CI) 100.0 % 0.47 [ 0.17, 1.28 ]
Heterogeneity: Tau2 = 0.18; Chi2 = 1.53, df = 1 (P = 0.22); I2 =35%
Test for overall effect: Z = 1.48 (P = 0.14)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours ITN Favours UTN
74Insecticide-treated nets for preventing malaria (Review)
Copyright © 2018 The Authors. Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The
Cochrane Collaboration.
Analysis 2.6. Comparison 2 Insecticide-treated nets versus untreated nets, Outcome 6 P falciparum
prevalence.
Review: Insecticide-treated nets for preventing malaria
Comparison: 2 Insecticide-treated nets versus untreated nets
Outcome: 6 P falciparum prevalence
Study or subgroup log [Risk Ratio] Risk Ratio Weight Risk Ratio
(SE) IV,Random,95% CI IV,Random,95% CI
D’Alessandro 1995 -0.0693 (0.0854) 75.0 % 0.93 [ 0.79, 1.10 ]
Luxemburger 1994 -0.2224 (0.4044) 3.3 % 0.80 [ 0.36, 1.77 ]
Snow 1987 -0.1833 (0.1589) 21.7 % 0.83 [ 0.61, 1.14 ]
Total (95% CI) 100.0 % 0.91 [ 0.78, 1.05 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.50, df = 2 (P = 0.78); I2 =0.0%
Test for overall effect: Z = 1.34 (P = 0.18)
Test for subgroup differences: Not applicable
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Analysis 2.7. Comparison 2 Insecticide-treated nets versus untreated nets, Outcome 7 P vivax prevalence.
Review: Insecticide-treated nets for preventing malaria
Comparison: 2 Insecticide-treated nets versus untreated nets
Outcome: 7 P vivax prevalence
Study or subgroup log [Risk Ratio] Risk Ratio Weight Risk Ratio
(SE) IV,Fixed,95% CI IV,Fixed,95% CI
Luxemburger 1994 -0.3925 (0.5146) 100.0 % 0.68 [ 0.25, 1.85 ]
Total (95% CI) 100.0 % 0.68 [ 0.25, 1.85 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.76 (P = 0.45)
Test for subgroup differences: Not applicable
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Analysis 2.8. Comparison 2 Insecticide-treated nets versus untreated nets, Outcome 8 Any Plasmodium
spp. prevalence.
Review: Insecticide-treated nets for preventing malaria
Comparison: 2 Insecticide-treated nets versus untreated nets
Outcome: 8 Any Plasmodium spp. prevalence
Study or subgroup log [Risk Ratio] Risk Ratio Weight Risk Ratio
(SE) IV,Fixed,95% CI IV,Fixed,95% CI
Magris 2007 -1.772 (0.5802) 100.0 % 0.17 [ 0.05, 0.53 ]
Total (95% CI) 100.0 % 0.17 [ 0.05, 0.53 ]
Heterogeneity: not applicable
Test for overall effect: Z = 3.05 (P = 0.0023)
Test for subgroup differences: Not applicable
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Analysis 2.9. Comparison 2 Insecticide-treated nets versus untreated nets, Outcome 9 Anaemia (mean
packed cell volume).
Review: Insecticide-treated nets for preventing malaria
Comparison: 2 Insecticide-treated nets versus untreated nets
Outcome: 9 Anaemia (mean packed cell volume)
Study or subgroup Mean Difference (SE)
Mean
Difference Weight
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
D’Alessandro 1995 0.3 (0.8231) 39.7 % 0.30 [ -1.31, 1.91 ]
Snow 1987 0.6 (0.6683) 60.3 % 0.60 [ -0.71, 1.91 ]
Total (95% CI) 100.0 % 0.48 [ -0.54, 1.50 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.08, df = 1 (P = 0.78); I2 =0.0%
Test for overall effect: Z = 0.93 (P = 0.35)
Test for subgroup differences: Not applicable
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A P P E N D I C E S
Appendix 1. Inclusion criteria for studies in the previous update of this review
Study designs Individual randomized controlled trials (RCTs) and cluster RCTs
Participants Children and adults living in rural and urban malarious areas
Excluded: trials examining only pregnant women and trials examining only soldiers or travellers, because they are
not representative of the general population
Interventions Bed nets or curtains treated with a synthetic pyrethroid insecticide at a minimum target impregnation dose of:
• 200 mg/m2 permethrin or etofenprox;
• 30 mg/m2 cyfluthrin;
• 20 mg/m2 alpha-cypermethrin;
• 10 mg/m2 deltamethrin/lambda-cyhalothrin.
No distinction was made between insecticide-treated bed nets and door/window/eave/wall curtains, which were
assumed to have approximately the same impact
Comparators Untreated net or no net
Outcomes • Child mortality from all causes: measured using protective efficacy and rate difference.
• Malaria-specific child mortality: measured using “verbal autopsy” reports that fulfil standard clinical criteria
for a probable malaria death (Snow 1992; Todd 1994).
• Severe disease: measured using site-specific definitions based on World Health Organization guidelines,
WHO 1990, and on Marsh 1995. The definition included Plasmodium falciparum parasitaemia. Cerebral malaria
was defined as coma or prostration and/or multiple seizures. The cut-off for severe, life-threatening anaemia was
set at 5.1 g/L (WHO 1990).
• Uncomplicated clinical episodes: measured using site-specific definitions, including measured or reported
fever, with or without parasitological confirmation. Measurements were usually done in the frame of prospective
longitudinal studies, but we also considered trials using validated retrospective assessments in the frame of cross-
sectional surveys. In areas with entomological inoculation rates below 1 (unstable malaria), we considered P
falciparum and P vivax episodes separately.
• Parasite prevalence: parasite prevalence due to P falciparum and P vivax was obtained using the site-specific
method for estimating parasitaemia, that is usually thick or thin blood smears or both. When more than one
survey was done, the reported prevalence result is the average prevalence of all the surveys.
Appendix 2. Search strategy
Cochrane Central Register of Controlled Trials
Issue 4 of 12, April 2018:
ID Search
#1 MeSH descriptor: [Malaria] explode all trees
#2 malaria:ti,ab,kw (Word variations have been searched)
#3 anopheles :ti, ab, kw
#4 MeSH descriptor: [Anopheles] explode all trees
#5 mosquito* :ti, ab, kw
#6 #1 or #2 or #3 or #4 or #5
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#7 (Net* or bednet* or ITN* or LLIN* or “Insecticide-Treated Bednet*” or “Insecticide-Treated net*”ti, ab,kw
#8 MeSH descriptor: Insecticide-Treated Bednets
#9 (Olyset* or PermaNet* or Veeralin):ti, ab, kw
#10 #7 or #8 or #9
#11 #6 and #10 with Publication Year from 2003 to 2018
PubMed (MEDLINE)
Search Query
#16 Search (#11) AND #15
#15 Search (#12) OR #13 OR #14 Filters: Publication date from 2003/01/01
#14 Search “drug therapy” [Subheading]
#13 Search “Randomized Controlled Trial” [Publication Type] OR “Controlled Clinical Trial” [Publication Type]
#12 Search randomized or placebo or randomly or trial or groups Field: Title/Abstract
#11 Search (#9) AND #10 Filters: Publication date from 2003/01/01;
#10 Search (#6) OR #7 OR #8 Publication date from 2003/01/01;
#9 Search (#1) OR #2 OR #3 OR #4 OR #5 Filters: Publication date from 2003/01/01;
#8 Search Olyset* or PermaNet* or Veeralin Field: Title/Abstract
#7 Search bednet* or net* or ITN* or LLIN* or curtain* or “insecticide-treated net*” or “insecticide-treated bednet*” Field:
Title/Abstract
#6 Search (“Insecticide-Treated Bednets”[Mesh]) OR “Mosquito Nets”[Mesh]
#5 Search malaria Field: Title/Abstract
#4 Search “Plasmodium”[Mesh]
#3 Search “Malaria”[Mesh]
#2 Search mosquito Field: Title/Abstract
#1 Search “Anopheles”[Mesh]
Embase
1 (malaria* or plasmodium or anopheles).mp.
2 insecticide-treated nets.mp. or insecticide treated net/
3 (bednet* or net* or ITN* or LLIN* or curtain*).ab. or (bednet* or net* or ITN* or LLIN* or curtain*).ti.
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4 (Olyset* or PermaNet* or Veeralin).ab. or (Olyset* or PermaNet* or Veeralin).ti.
5 2 or 3 or 4
7 1 and 5
8 limit 7 to yr=“2003 -Current”
9 randomized controlled trial/ or controlled clinical trial/
10 ((randomi?ed ) or (singl$ or doubl$ or trebl$ or tripl$) adj (blind$ or mask$)) .ab. or ((randomi?ed) or (singl$ or doubl$ or trebl$
or tripl$) adj (blind$ or mask$)).ti.
11 9 or 10
12 8 and 11
LILACS
(tw:(bednets OR nets OR itn )) AND (tw:(malaria OR mosquito OR anopheles)) AND (tw:(randomized OR controlled OR trial OR
comparison OR compared ))
ClinicalTrials.gov and WHO ICTRP
insecticide treated nets and Malaria
Appendix 3. Revised protocol for review update (2018)
Protocol section Refreshed protocol
Background • We updated information in the background to reflect the changes in global malaria distribution and its
control since the previous update.
• We included further information on insecticide resistance and the need to consider this when evaluating
the effectiveness of ITNs.
Methods • The primary objective of the review, to assess the impact of ITNs on mortality and malarial illness,
remains relevant. The original PICO remains relevant.
• In the previous review, mortality data was age-standardized across each included study by extracting only
the number of deaths and total number of participants within a high-risk age group of 1 to 59 months. To
avoid the exclusion of potentially useful information, we planned to extract mortality data for children of all
ages who participated in the included studies. However, we also planned to calculate the baseline risk in the
high-risk age group by extracting the number of deaths and total number of children aged 1 to 59 months.
From this we estimated the impact of ITNs on mortality in the high-risk age group.
• For the secondary outcomes, summary risk and rate ratios were previously presented without CIs, as
cluster-adjusted CIs were not available for all trials. If an included cRCT did not adjust for clustering, we
planned to adjust the data using an imputed design effect. The cRCTs were then meta-analysed, and cluster-
adjusted CIs for each outcome were provided.
• We excluded the outcomes of splenomegaly, high parasitaemia, and anthropometric measures, which were
considered in the previous review (Lengeler 2004), as we did not consider them priority outcomes at the time of
this update.
• We updated our approach to assessing risk of bias, and used the standardized Cochrane’s ‘Risk of bias’ tool.
For each included cRCT we also assessed five additional criteria relating specifically to cRCTs.
• We included all relevant trials in the meta-analysis regardless of the local area’s transmission intensity, and
intended to subgroup between stable and unstable transmission only if we identified substantial heterogeneity.
• We assessed the certainty of the evidence using the GRADE approach.
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WH A T ’ S N E W
Date Event Description
6 November 2018 New citation required but conclusions have not
changed
We excluded the outcomes of splenomegaly, high par-
asitaemia, and anthropometric measures, which were
considered in the previous review (Lengeler 2004).
In this update we extracted mortality data for children
of all ages who participated in the included studies.
However, we also calculated the baseline risk in the
high-risk age group by extracting the number of deaths
and total number of children aged 1 to 59 months.
From this we estimated the impact of ITNs on mortal-
ity in the high-risk age group
For the secondary outcomes, summary risk and rate ra-
tios were previously presented without CIs, as cluster-
adjusted CIs were not available for all trials. If an in-
cluded cRCT did not adjust for clustering, we adjusted
the data using an imputed design effect. The cRCTs
were then meta-analysed, and cluster-adjusted CIs for
each outcome were provided
6 November 2018 New search has been performed This is an update of the Lengeler 2004 review. We per-
formed a literature search update, and included three
articles, reporting three new trials, and five new articles
relating to trials included in the previous update. We
excluded two trials included in the previous version of
the review. We assessed the certainty of the evidence us-
ing the GRADE approach. We assessed the risk of bias
for each included study in this update using Cochrane’s
‘Risk of bias’ tool; for each included cRCT, we also
assessed five additional criteria relating specifically to
cRCTs
H I S T O R Y
Protocol first published: Issue 1, 1995
Review first published: Issue 3, 1998
Date Event Description
18 August 2008 Amended Converted to new review format with minor editing.
19 January 2004 New citation required but conclusions have not
changed
Issue 2, 2004
This is a major update with a revision of the text, tables,
and results.
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(Continued)
- An additional 16 trials have been identified and re-
viewed, of which 4 were included.
- The sensitivity analysis (with group 2 trials) has been
removed to clarify the main results.
- The literature in all sections and especially background
and discussion has been updated.
- Overall mortality results have been entered with the
reverse variance function in order to present confidence
intervals adjusted for clustering
12 January 2004 New search has been performed Minor update.
23 October 2003 New search has been performed New studies sought but none found.
21 January 2003 New search has been performed New studies found and included or excluded.
C O N T R I B U T I O N S O F A U T H O R S
JP conducted the search and screened studies published between 2004 and 18 April 2018; rescreened studies from the previous review
against the new inclusion criteria; extracted study characteristics and outcome data from all included studies; assessed the risk of bias
using new tools; conducted the meta-analyses using cluster-adjusted data and graded the certainty of the evidence; and prepared the
final manuscript.
MR provided statistical support throughout.
CL conducted the original search and screened all studies up to 2004. For the previous review, CL extracted information from the
included studies; assessed risk of bias; conducted analyses; and prepared the manuscript following the previous review’s methodology.
For this review update, CL provided guidance on data extraction; conducting the GRADE analysis; and assisted with the manuscript
preparation.
All review authors have read and approved the final manuscript.
D E C L A R A T I O N S O F I N T E R E S T
JP has no known conflicts of interest.
MR has no known conflicts of interest.
CL has no known conflicts of interest.
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S O U R C E S O F S U P P O R T
Internal sources
• Liverpool School of Tropical Medicine, UK.
External sources
• Department for International Development (DFID), UK.
Project number 300342-104
• World Health Organization (WHO), Switzerland.
WHO Global Malaria Programme Agreement for Performance of Work (APW) Grant 2017 (number 709319)
D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
N/A.
Differences between revised protocol and review update
Before conducting the review update, the review author team revised the original published protocol, Lengeler 1995 (see Appendix 3).
We had intended to perform two pre-specified subgroup analyses: one that subgrouped according to malaria transmission stability and
a second that subgrouped cRCTs from individual RCTs. However, we did not perform either analysis as we only detected substantial
heterogeneity in one outcome, for which the contributing studies were all cRCTs in unstable malaria transmission settings. Subgrouping
would therefore not have provided any insight into the heterogeneity. Otherwise, we followed the methods specified in the revised
protocol (Appendix 3) and Methods section.
I N D E X T E R M S
Medical Subject Headings (MeSH)
∗Bedding and Linens; Insecticides [∗administration & dosage]; Malaria [∗prevention & control]; Malaria, Falciparum [prevention &
control]; Malaria, Vivax [prevention & control]; Mosquito Control [∗methods]; Randomized Controlled Trials as Topic
MeSH check words
Female; Humans; Male; Pregnancy
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